col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


543 Results       Page 1

 [1] 
American Society of Clinical Oncology: Journal of Clinical Oncology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―22 Impact of the COVID-19 pandemic on colorectal cancer stage at presentation. Malcolm Hart Squires, Nicole Lindolm, Reilly Shea, Erin E. Donahue, Michelle Wallander, Jonathan C. Salo
2 [GO] 2024―Jan―22 Advanced pancreatic cancer outcomes and the impact of COVID-19 pandemic: The experience of an academic cancer center. Christian Adams-Carey, Anna Shepard, Katie Moreland, Olugbenga Olanrele Olowokure, Tahir Latif, Adam Rojan, et al. (+3)
3 [GO] 2023―Aug―09 On Cancer Screening During the COVID-19 Pandemic Otis W. Brawley
4 [GO] 2023―Jun―04 Outcome of deep venous thrombosis and pulmonary embolism in COVID-19 cancer patients vs non-cancer patients. Can Jones, Kristina D. Menchaca, Catherine Ostos, Mohamed Elsheshtawi, Virginia Velez-Quinones, Shachar Peles, Hayder Saeed
5 [GO] 2023―Jun―04 Association of frailty index of laboratory tests (FI-LAB) and COVID-19 clinical outcomes in veterans with cancer. Natasha Melo Resendes, Ekta Panjrolia, Toufic Tannous, Armando Sarasua, Jorge G. Ruiz, Krystal Hasel, et al. (+2)
6 [GO] 2023―Jun―04 Psychological impact of COVID-19 vaccination in patients with cancer: The VACCINATE study. Daniela Tregnago, Alice Avancini, Lorenzo Belluomini, Ilaria Trestini, Marco Sposito, Jessica Insolda, et al. (+12)
7 [GO] 2023―Jun―04 The impact of COVID-19 on a stand-alone cancer support community. Carley Mitchell, Jeffrey Zhong, Cheryl Apisdorf, Beth Bennett, Qian Wang, Melinda Laine Hsu
8 [GO] 2023―Jun―04 Cancer survivorship: Patient experiences on early phase trials during the COVID-19 pandemic-Qualitative study from an Australian Phase 1 unit. Oksana Zdanska, Anthony M. Joshua, Jia (Jenny) Liu, Pavel Zdansky, Melinda Stanners, Cath Rogers
9 [GO] 2023―Jun―04 How did the COVID-19 pandemic affect the management of patients with cancer? What is the impact of anti-cancer medications on the immune response to the COVID-19 vaccinations?. Mahmoud Abdelsalam, Maged Salem, Alexander McPherson, Nizar Abdel-Samad, Pierre Obrien, Laura Ross, et al. (+2)
10 [GO] 2023―Jun―04 Gynecologic oncology patients’ perception of physician empathy in the age of COVID-19. Gavriel Cohn, Bradford Whitcomb
11 [GO] 2023―Jun―04 The impact of COVID-19 on anxiety among breast cancer survivors before, during and after the pandemic. Edison Tsui, Katherine Reeves, Isabella Caruso, Grace Makari-Judson
12 [GO] 2023―Jun―04 Immunogenicity after COVID-19 vaccination in patients with solid tumor and hospital staff: A prospective single-center observational study. Yuki Katsuya, Tatsuya Yoshida, Shu Yazaki, Shigehiro Yagishita, Hiroko Nakahama, Osamu Kobayashi, et al. (+4)
13 [GO] 2023―Jun―04 Risk of death among lung cancer patients before and during the COVID-19 pandemic. Teddy Tai Loy Lee, Danyang Zheng, Sichao Wang, Abraham Ka Chung Wai, Feng-Ming Spring Kong
14 [GO] 2023―Jun―04 Newly diagnosed lung cancer in hospitalized patients during the COVID-19 pandemic: How well are LDCTs utilized? Jonathan Assis, Thanuja Neerukonda, Bilal Farooqi, Mahvish Haider
15 [GO] 2023―Jun―04 Impact of the Covid-19 pandemic on the treatment of resectable liver neoplasms: A cross-sectional study from Brazil. Marina Marangoni Roschel, Laynara Vitória Da Silva Vieira, Narjust Florez, Monique Vilela Gomes, Yasmin Alves Peterson, Beatriz Meneses, et al. (+13)
16 [GO] 2023―Jun―04 Remote delivery of a mindfulness-based intervention to decrease stress levels and promote coping among health-care workers during the COVID-19 pandemic. Joelle Antoine Helou, Aisling S Barry, Philip Ye, Fei-Fei Liu, Anet Julius, Daniel Letourneau, et al. (+3)
17 [GO] 2023―Jun―04 Clinical course and native antibody development after COVID-19 infection in 50 pediatric oncology patients. Maeve Smart, Olivia Puopolo, Matthew R Chang, Hanzhong Ke, Wayne A Marasco, Catherine R. Marinac, et al. (+4)
18 [GO] 2023―Jun―04 Real-world effectiveness of prophylactic tixagevimab-cilgavimab monoclonal antibodies on incidence and severity of COVID-19 infection in patients with cancer. Maryam Naser, Prarthna V Bhardwaj, Fatima Zahid Warriach, Yamna Jadoon, Kush Gupta, Vida Rastegar, et al. (+2)
19 [GO] 2023―Jun―04 COVID-19 and prevalence of venous thromboembolism among cancer patients: A nationwide inpatient sample analysis. Muhammad Bilal Ibrahim, Rafaella Litvin, Hiba Noor, Ali Husnain Khan, Michelle Ishaya, Khaldun Obeidat, et al. (+7)
20 [GO] 2023―Jun―04 Outcomes of venous thromboembolism among cancer patients admitted with COVID-19: A nationwide inpatient sample analysis. Muhammad Bilal Ibrahim, Rafaella Litvin, Hiba Noor, Ali Husnain Khan, Mihir Shah, Philip Onyekaoso Kanemo, et al. (+6)
21 [GO] 2023―Jun―04 Retrospective analysis of the effect of COVID-19 in hospitalized cancer patients. Senin Shah, Akil Adrian Sherif, Andrew Hsu
22 [GO] 2023―Jun―04 Under-screened: COVID-19 lockout measures and the reduction of early-stage cancer patients’ consultations in Argentina. Ernesto Gil Deza, Gaston Martin Reinas, Liliana D. Gonzalez, Isaias Gil Deza, Monica Montiel, Carlos Garcia Gerardi, et al. (+9)
23 [GO] 2023―Jun―04 Association of COVID-19 pandemic with indolent lymphoma care delivery and outcomes in Ontario, Canada: A population-based analysis. Michael Crump, Inna Y. Gong, Zharmaine Ante, Andrew Calzavara, Matthew Cheung, Anca A. Prica
24 [GO] 2023―Jun―04 Did COVID-19 impact national trends of hospitalization and outcomes for neutropenic fever in adults with cancer? Prarthna V Bhardwaj, Lekha Yadukumar, Ishani Patel, Deepak Pasupula, Chandravathi Loke, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa
25 [GO] 2023―Jun―04 Real-world healthcare resource utilization (HCRU) and costs among patients with hematologic or solid tumor malignancy (STM) with COVID-19 in a commercially insured or Medicare Advantage population. Dennis J Cunningham, Vincent J Willey, Lia Pizzicato, Michael Pollack, Cachet Wenziger, Lisa Glasser, et al. (+4)
26 [GO] 2023―Jun―04 COVID-19 vaccination, infection, and symptoms among cancer survivors in the United States during 2021. Nova Yang, Xuesong Han, Robin Yabroff, Jingxuan Zhao, Zhiyuan Zheng
27 [GO] 2023―Jun―04 Chronic leukemias and COVID-19: An analysis of mortality and morbidity outcomes in the United States. Ziad Abuhelwa, Ahmad Y Abuhelwa, Mohammad Safi, Jehad Zeidalkilani, Andrew Abrahamian, Sadik Khuder, Roland T. Skeel
28 [GO] 2023―Jun―04 The impact of Covid-19 pandemic on breast cancer multidisciplinary management at the Vall d'Hebron University Hospital. Isabel Pimentel, Cristina Viaplana, Carolina Ortiz, Guillermo Villacampa, Juan Aguilar-Company, Ana Rodriguez, et al. (+7)
29 [GO] 2023―Jun―04 Risk factors for in-hospital mortality in cancer patients hospitalized for COVID-19. Ziad Abuhelwa, Ahmad Y Abuhelwa, Mohammad Safi, Caleb Spencer, Mazzin Haitham Elsamaloty, Roland T Skeel, Sadik Khuder
30 [GO] 2023―Jun―04 The impact of COVID-19 on patient involvement in treatment decisions in the US and EU4+UK. Elsa Ng, Angelena Moseley, Federico Gallo
31 [GO] 2023―Jun―04 The impact of COVID-19 on the survival outcome of lung cancer at a Canadian academic centre: A real-world data analysis. Jason S. Agulnik, Goulnar Kasymjanova, Carmela Pepe, Jennifer Friedmann, David I. Small, Lama Sakr, et al. (+3)
32 [GO] 2023―Jun―04 COVID-19 pandemic impact on the oncology care using a virtual survey in Peru. Guillermo Valencia, Daniel Enriquez, Patricia Rioja, Lizbeth Lachira, Monica Calderon, Jeannie Navarro-Vasquez, et al. (+2)
33 [GO] 2023―Jun―04 The impact of the COVID-19 pandemic on the diagnosis and treatment of breast cancer at a community hospital. Matthew McGee, Barbara Bennie, Alec Fitzsimmons, Andrea Arenz, Leah L. Dietrich
34 [GO] 2023―Jun―04 Increasing COVID-19 vaccine adherence within an immunocompromised patient population in a community practice. Jane Charlotte Tolkinen, Carolyn Anne Carrera, Sunaina Gowda Ramesh Babu, Barry DeCicco
35 [GO] 2023―Jun―04 False positive PET scan in patients with treated malignancy following COVID-19 vaccination. Alexander Antoni Slota, Vrajesh Parmar, Amy M. Weise, Ding Wang
36 [GO] 2023―Jun―04 The COVID-19 pandemic's impact on diagnosis of cancers detectable through screening. Carmen Guerra, Peter Edward Gabriel, Abigail Doucette, Colleen M Grosso, Armenta L. Washington, Emily Verderame, et al. (+14)
37 [GO] 2023―Jun―04 Impact of COVID-19 pandemic on lung cancer diagnosis in a community hospital. Sumukh Arun Kumar, Abinesh Sekar, Abhishek Singh, Sharmitha Ravichandran, Rahul Mishra, Ahmad Daniyal Siddiqui
38 [GO] 2023―Jun―04 Ethnic disparity in hospitalization among veterans with COVID-19 and cancer. Maya Gogtay, Ruchi Kaushik, Nicolina Martinez, Michael Mader, Sandra Sanchez-Reilly, Marcos I. Restrepo
39 [GO] 2023―Jun―04 Effect of the large waves of COVID-19 on false-positive results in annual lung cancer screening. Tatsuo Kimura, Shinya Fukumoto, Akemi Nakano, Sawako Uchida, Yuji Nadatani, Yukie Tauchi, et al. (+6)
40 [GO] 2023―Jun―04 Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance). Jennifer Ann Woyach, Jun Yin, Jennifer R. Brown, Shira Dinner, Gerard Lozanski, Richard F. Little, et al. (+14)
41 [GO] 2023―Jun―04 Assessing changes in cancer-related financial support needs across three waves of the COVID-19 pandemic. Bridgette Thom, Andrea Incudine, Neha Arora, Thomas Stivers, Katharine Winder, Fumiko Chino
42 [GO] 2023―Jun―04 COVID-19 infection in patients on anti-CD20 monoclonal antibodies: Changes in clinical outcomes and management over time. Mohammad Ali, Hafez M Abdullah, Mamoon Ahmed, Hammad Chaudhry, Dawlat Khan, Fouad Khalil, et al. (+2)
43 [GO] 2023―Jun―04 Rural cancer care delivery during the COVID-19 pandemic for patients with early-stage cancer. Izumi Okado, Michelle Liu, Carry Elhajj, Lynne Wilkens, Randall F. Holcombe
44 [GO] 2023―Jun―04 Implications for acute myeloid leukemia (AML) treatment and care during the COVID-19 pandemic: A Connect Myeloid Registry study. Bart L. Scott, Mikkael A. Sekeres, Guillermo Garcia-Manero, David L. Grinblatt, Irene S. DeGutis, Pavel Kiselev, et al. (+4)
45 [GO] 2023―Jun―04 Association of socioeconomic status (SES) with use of specialist palliative care (SPC) among people who died with cancer before and during the COVID-19 pandemic. Javaid Iqbal, Rahim Moineddin, Robert Fowler, Monika K. Krzyzanowska, Christopher M. Booth, James Downar, et al. (+9)
46 [GO] 2023―Jun―04 Impact of the COVID-19 pandemic on insurance transitions among commercially insured cancer patients in Washington state. Scott David Ramsey, Qin Sun, Catherine R. Fedorenko, Aasthaa Bansal, Karma L. Kreizenbeck, Veena Shankaran
47 [GO] 2023―Jun―04 Antitumor regimens with gemcitabine are safe for tumor patients with COVID-19. Yuanqiang Wu, Weini Quan, Jinan Ma, Zhenjiang Li
48 [GO] 2023―Jun―04 Effect of COVID-19 on mortality in patients admitted for DVT/PE with pre-existing cancer diagnosis at the beginning of the COVID-19 pandemic: A national inpatient sample study. Andrew Campbell, Ziad Abuhelwa, Danae M. Hamouda
49 [GO] 2023―Jun―04 COVID-19 vaccination in patients with cancer: Results from survey based observational study. Hyma Vani Polimera, Lauren Danielle Pomerantz, Emma Guare, Junjia Zhu, Monika Joshi
50 [GO] 2023―Jun―04 Impact of COVID-19 pandemic on breast cancer screening rates. Cliff Rutter, Elisea Avalos-Reyes, Rogelio A. Brito, Kelly Craig, Dorothea J. Verbrugge, Chen Liu, et al. (+2)
51 [GO] 2023―Jun―04 The impact of COVID-19 on national trends of hospitalization and outcomes for acute leukemias. Prarthna V. Bhardwaj, Sneha Nagesh Rao, Deepak Pasupula, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa
52 [GO] 2023―Jun―04 The same outcome of cancer patients treated with radiotherapy or chemoradiotherapy regardless COVID-19 status. Zhenyu Zhang, Ping Li, Juan Zhou, Qinghai Lin, Xun Peng, Xue Meng, et al. (+3)
53 [GO] 2023―Jun―04 The effects of the Covid-19 pandemic on practice patterns and outcomes in patients diagnosed with gynecologic malignancies in the United States. Adrian Kohut, Nicole Lugo Santiago, Rosemary Senguttuvan, Ernest Soyoung Han, Joshua Garrett Cohen, Stephen Lee, et al. (+5)
54 [GO] 2023―Jun―04 Effect of SNPs in TMPRSS2 to severe COVID-19 in patients with prostate cancer. Melanie Claps, Elena Jachetti, Fabio Badenchini, Ida Taglialatela, Irene Tripodi, Renata Ferri, et al. (+14)
55 [GO] 2023―Jun―04 Impact of obesity on admissions for COVID-19 with concurrent prostate cancer. Renuka Verma, Kamleshun Ramphul, Mehndi Dandwani, Shivani Sharma, Suma Sri Chennapragada, Alekhya Pagidipally, et al. (+9)
56 [GO] 2023―Jun―04 Impact of COVID-19 pandemic on the treatment of prostate cancer in the Brazilian public health system. Gustavo Carvalhal, Igor Alexandre Protzner Morbeck, Daniel Herchenhorn, Andre Deeke Sasse, Rana R. McKay, Brent Shane Rose, et al. (+9)
57 [GO] 2023―Jun―04 Effect of the COVID-19 pandemic on radical prostatectomy: A Brazilian retrospective study. Marina Marangoni Roschel, Laynara Vitória Da Silva Vieira, Narjust Florez, Monique Vilela Gomes, Alana Bruna Krug, Luana Dornelas, et al. (+13)
58 [GO] 2023―Jun―04 Analysis of patients at the Memphis VA Medical Center with positive FIT testing and incomplete GI evaluation during the COVID-19 pandemic. Mark Mitchell, Richard Huynh, Lindsey Lands, Alva B Weir
59 [GO] 2023―Jun―04 Colorectal cancer screening and treatment before and during the COVID-19 pandemic at a Southeast Texas community hospital. Ahmed Abdelhakeem, Muhammad Siddiqi, Nigil Thaimuriyil, Chelsey Peters, Samantha Blevins, Tahir A. Naqvi
60 [GO] 2023―Jun―04 The impact of COVID-19 on mortality, length of stay, and cost of care among patients with gastrointestinal malignancies: A propensity score-matched analysis. Mark Bilinyi Ulanja, Bryce D. Beutler, Samuel B Governor, Kwabena Oppong Asafo-Agyei, Samuel Edusa, Daniel Antwi-Amoabeng, et al. (+7)
61 [GO] 2023―Jun―04 Predictors of re-admission after COVID-19 hospitalizations in patients with underlying gastrointestinal malignancy. Mihir Shah, Rohan Gajjar, Vaishali Deenadayalan, Michelle Ishaya, Rafaella Litvin, Muhammad Bilal Ibrahim, et al. (+2)
62 [GO] 2023―Jun―04 Hypersensitivity reaction to taxanes following COVID-19 vaccination. Bennett Osantowski, Mariah Ondeck, Nerea Lopetegui-Lia, Yanwen Chen, Wei Wei, Sowmya Takkellapati, Halle C. F. Moore
63 [GO] 2023―Jun―04 COVID-19 induced remission of biliary and renal cell carcinomas. Jocelyn L Tan
64 [GO] 2023―Jun―04 Clinical outcomes in patients with metastatic non-small cell lung cancer and head and neck squamous cell cancer treated with immune checkpoint inhibitors according to COVID-19 vaccination status. Karam Khaddour, Josette Mary Kamel, Natalie Meeder, Xu Ziqiao, Cuellar Sandra, Mary Pasquinelli, et al. (+5)
65 [GO] 2023―Jun―04 Analysis of tumor progression among patients with glioma after COVID-19 infection. Tim Gregory, Stephanie Knight, Ashley Aaroe, Barbara Jane O'Brien, Chirag B Patel, Shiao-Pei S. Weathers, et al. (+3)
66 [GO] 2023―Jun―04 Association of presenting symptoms with COVID-19 disease severity and outcomes among hospitalized patients with cancer and COVID-19. Noman Ali, Ed Kheder, Kodwo Dickson, David Rubio, Kwame Koom-Dadzie, Paul Edelkamp, et al. (+9)
67 [GO] 2023―Jun―04 Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials. Joseph M. Unger, Caroline Schenkel, Hillary Stires, Laura Levit, Mark Stewart, Brittany Avin McKelvey, et al. (+14)
68 [GO] 2023―Jun―04 Disparate impact of healthcare access restrictions due to COVID-19 pandemic on breast cancer diagnosis and treatment. Devi Nair, Rakhshanda Layeequr Rahman, Karla Daniele, Brooke Jensen, Chathurika S. Dhanasekara
69 [GO] 2023―Jun―04 Changes in time to treatment initiation for patients diagnosed with breast, lung, colon, or rectal cancer during the 2020 COVID-19 pandemic in the US. Qinjin Fan, Weichuan Dong, Elizabeth Schafer, Nikita Sandeep Wagle, Jingxuan Zhao, Kewei Sylvia Shi, et al. (+3)
70 [GO] 2023―Jun―04 Using telehealth to conduct serious illness conversations (SIC) for patients with metastatic lung cancer during the COVID-19 pandemic. Tejaswini More Dhawale, Roopa Sriram Bhat, Patrick Connor Johnson, Shanivi Srikonda, Kelsey S. Lau-Min, Kofi Boateng, et al. (+5)
71 [GO] 2023―Jun―04 Rural disparities in telemedicine use among cancer survivors during the COVID-19 pandemic. Min Jee Lee, Meng-Han Tsai
72 [GO] 2023―Jun―04 Telemedicine and cancer care in Syria: A promising initiative during the war and COVID-19 era. Maher Saifo, Mousa Alali
73 [GO] 2023―Jun―04 “You matter”: Patient reported outcomes on cancer disparities related to the COVID-19 pandemic. Mohamed Mohanna, Saad Sabbagh, Barbara Dominguez, Mira Itani, Ludovic Saba, Sindu Iska, et al. (+3)
74 [GO] 2023―Jun―04 Possible advantage of granulocyte colony-stimulating factor in breast cancer chemotherapy during COVID-19 pandemic: A single center experience in Japan. Kioto Yokoyama
75 [GO] 2023―Jun―04 Effects of the coronavirus disease 2019 pandemic on anxiety and spirituality in patients with cancer undergoing chemotherapy: A cross-sectional study. Francisca Fernanda Barbosa Oliveira, Rosane Oliveira Sant'Ana, Anna Clara Aragão Matos Carlos, André Alves Crispim, Lívia Moreira Caetano Coelho, Cássia Emanuella Nóbrega Malta, et al. (+6)
76 [GO] 2023―Jun―04 Immunocompetent and immunocompromised cancer populations: Post-vaccination humoral and cellular immune responses against SARS-CoV-2. Elizabeth Titova, Veronica W Kan, Andrew Ip, Tara Lozy, Kileen Shier, Vittal P Prakash, et al. (+11)
77 [GO] 2023―Jun―04 Racial disparities and clinical outcomes among cancer patients admitted with SARS-CoV-2 infection: A nationwide analysis. Vaishali Deenadayalan, Siri Chandana Swarna, Jay Vakil, Junglee Kim, Ekrem Turk, Shweta Gupta
78 [GO] 2023―Jun―04 Effect of SARS-CoV-2 mRNA vaccine booster in serologically negative patients with thymic epithelial tumors. Erica Pietroluongo, Pietro De Placido, Rocco Morra, Roberto Buonaiuto, Margherita Tafuro, Alessandra Longobardi, et al. (+14)
79 [GO] 2023―Jun―04 Impact of vaccine hesitancy on antibody response after SARS-CoV-2 vaccination in patients with cancer. Oliver Overheu, Simon Lendowski, Daniel R. Quast, Daniel Kuehn, Elena Vidal Blanco, Celine Lugnier, et al. (+6)
80 [GO] 2023―Jun―04 Association of SARS-CoV-2 vaccinations and personal protective measures with seroconversion and risk of infection in a large real-world cohort of patients with cancer. Thomas Michaeli, Niklas Thilo, Daniel Tobias Michaeli, Helge Beth, Friederike Hoffmann, Melanie Janning, et al. (+3)
81 [GO] 2023―Jun―04 Impact of SARS-COV2 infection on the clinical outcomes in patients with lung cancer. Siri Chandana Swarna, Vaishali Deenadayalan, Rafaella Litvin, Mona Dasgupta, Junglee Kim, Shweta Gupta
82 [GO] 2023―Jun―04 Impact of SARS-COV2 infection on the clinical outcomes in patients with lung cancer compared to all other cancers. Vaishali Deenadayalan, Mona Dasgupta, Ali Shahbaz Baloch, Siri Chandana Swarna, Junglee Kim, Shweta Gupta
83 [GO] 2023―Jun―04 The impact of SARS-CoV2 Omicron variants epidemic on patients with cancer in China. Ping Xiao, Diansheng Zhong, Linlin Zhang
84 [GO] 2023―Jun―04 SARS-CoV2 vaccination response in pediatric oncology patients. Amber Marie D'Souza, Manu Gnanamony, Maria Thomas, Thu Hien Nguyen, Pedro Antonio de Alarcon
85 [GO] 2023―Jun―04 Neoadjuvant endocrine therapy for early-stage breast cancer: An institutional experience during the COVID19 pandemic. Anne Christine Buteau, Mary D. Chamberlin, Steven Tau, Todd W. Miller
86 [GO] 2023―Jun―04 Trends and disparities in oncology telehealth after the initial pandemic era. Michael Jisoo Lee, Liisa Lyon, Carol Andrea Conell, Hongxin Sun, Brandon Anderson, Elad Neeman, et al. (+5)
87 [GO] 2023―Jun―04 Impact of pandemic on accrual of minority participants to interventional cancer clinical trials. Jaia Wingard, Vicki Sallee, Peter Edward Gabriel, Abigail Doucette, Wallace P Wormley, Colleen M. Grosso, et al. (+6)
88 [GO] 2023―Jun―04 Impact of the COVID pandemic on reporting of breast cancer cases and mortality. Rhami Khorfan, Jukes P. Namm, Halley P Vora, Naveenraj Livingstone Solomon, Sharon S. Lum
89 [GO] 2023―Jun―04 Post pandemic reality in breast cancer in Brazil. Sabina B. Aleixo, Jose Zago Pulido, Narelle Parmanhane
90 [GO] 2023―Jun―04 Clinical remission rates in patients with epithelial ovarian cancer in the pandemic versus the pre-pandemic period. Natalie Shammas, Amrita Mukherjee, Lanfang Xu, Kimberly L. Cannavale, Elizabeth A. Szamreta, Matthew Monberg, et al. (+2)
91 [GO] 2023―Jun―04 Clinical outcomes of patients with cancer before the SARS COV2 pandemic vs during the pandemic: A nationwide analysis. Siri Chandana Swarna, Vaishali Deenadayalan, Ali Shahbaz Shehbaz Baloch, Junglee Kim, Shweta Gupta
92 [GO] 2023―Jun―04 Effect of pandemic-related reductions in cancer care delivery on different US health systems. Lauren M Janczewski, Joseph Cotler, Ryan P Merkow, Bryan E Palis, Heidi Nelson, Timothy Mullett, Daniel J Boffa
93 [GO] 2023―Mar―14 A retrospective review of primary prophylaxis with granulocyte-colony stimulating factor (G-CSF) for patients with genitourinary malignancies receiving chemotherapy during the COVID-19 pandemic and implications for the future. Nely Mercy Diaz Mejia, Carlos Stecca, Di Maria Jiang, Nazanin Fallah-Rad, Philippe L. Bedard, Vikaash Kumar, et al. (+8)
94 [GO] 2023―Mar―14 COVID-19 vaccination behavior and outcomes in patients with genitourinary cancer in comparison with other cancer types. Hyma Vani Polimera, Lauren Danielle Pomerantz, Emma Guare, Junjia Zhu, Monika Joshi
95 [GO] 2023―Mar―14 COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors. Danielle Gilbert, Junxiao Hu, Elaine T. Lam
96 [GO] 2023―Mar―14 Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer. Dorothy Kenny, Jue Wang
97 [GO] 2023―Mar―14 Surgery for urologic cancers after SARS-CoV-2 infection: Adverse outcomes and optimal delay. Madelyn Anne Flitcroft, Nathaniel Verhagen, Nayan Shah, Scott Johnson, Anai Kothari
98 [GO] 2023―Mar―14 Impact of vaccination against SARS-CoV-2 on the risk of hospital admission and death among infected patients with urologic cancers: A population-based study in northern Italy. Lucia Fratino, Michele Gobbato, Elena Clagnan, Martina Taborelli, Stefania Del Zotto, Federica Toffolutti, et al. (+4)
99 [GO] 2023―Feb―23 Cancer Screening in the United States During the Second Year of the COVID-19 Pandemic Jessica Star, Priti Bandi, Rebecca L. Siegel, Xuesong Han, Adair Minihan, Robert A. Smith, Ahmedin Jemal
100 [GO] 2023―Feb―03 Impact of the COVID-19 Pandemic on Cancer Screening Delays Xiaochen Zhang, Mohamed I. Elsaid, Cecilia DeGraffinreid, Victoria L. Champion, Electra D. Paskett, Guy Brock, et al. (+9)
101 [GO] 2023―Jan―31 Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer Marco Tagliamento, Alessandra Gennari, Matteo Lambertini, Ramon Salazar, Nadia Harbeck, Lucia Del Mastro, et al. (+47)
102 [GO] 2023―Jan―24 Pre-diagnostic delay among patients with curative esophageal and gastric cancer during the COVID-19 pandemic. Xin Wang, Osvaldo Espin-Garcia, Yvonne Bach, Hiroko Aoyama, Lucy Xiaolu Ma, Carly C. Barron, et al. (+12)
103 [GO] 2023―Jan―24 Impact of COVID-19 pandemic on diagnosis, staging, and outcomes of patients with early-onset colorectal cancer. Daniel Martinez-Perez, David Viñal, Jose Ángel García Cuesta, Antonio Rueda-Lara, Iciar Ruiz-Gutierrez, Diego Jiménez-Bou, et al. (+14)
104 [GO] 2023―Jan―24 Impact of COVID-19 pandemic on pancreatic cancer disparities and outcomes in Florida. Alexander Lim, Guettchina Telisnor, Zhongyue Zhang, XiangYang Lou, Ibrahim Nassour, Ramzi Salloum, Sherise C. Rogers
105 [GO] 2023―Jan―24 Patient perspectives on colorectal cancer care delivery during the COVID-19 pandemic: A qualitative interview study. Rozanne Wilson, Maria Cecilia Vieira, Meaghan Roach, Nadya Prood, Anjali Belani, Laura Mesana, Suepattra Grace May
106 [GO] 2023―Jan―24 Impact of chemotherapy on COVID-19 vaccination in patients with gastrointestinal cancer. Mitsukuni Suenaga, Shinichi Yamauchi, Yuya Sato, Rika Noji, Ryo Morikawa, Yoshihito Kano, et al. (+2)
107 [GO] 2022―Dec―01 Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS Report Smita Bhatia, Chen Dai, Lindsey Hageman, Jessica Wu, Elizabeth Schlichting, Arianna Siler, et al. (+14)
108 [GO] 2022―Nov―23 Effect of the COVID-19 Pandemic on Place of Death Among Medicaid and Commercially Insured Patients With Cancer in Washington State Laura E. Panattoni, Cara L. McDermott, Li Li, Qin Sun, Catherine R. Fedorenko, Hayley A. Sanchez, et al. (+3)
109 [GO] 2022―Oct―06 Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis David Hui, Nico Nortje, Marina George, Kaycee Wilson, Diana L. Urbauer, Caitlin A. Lenz, et al. (+14)
110 [GO] 2022―Sep―30 The Colorectal Cancer Alliance: Reshaping volunteerism during COVID-19. Kim Newcomer, Ali Miller, Negeen Fathi, Abdullah Shoeb
111 [GO] 2022―Sep―30 COVID-19 admissions among patients with cancer, characterization, and at-home monoclonal antibody treatment. Amy Iarrobino Laughlin, Allison Steyl, Beth Ingle Emsley, Terra Warner, Andrea Ledford, Richard M Basaly, et al. (+4)
112 [GO] 2022―Sep―30 COVID-19 clearance among patients with cancer during the Delta and Omicron waves. Zachary M Avigan, Rodrigo Paredes, Leora S Boussi, Barbara Lam, Meghan Shea, Matthew Weinstock, Mary Linton Bounetheau Peters
113 [GO] 2022―Sep―30 COVID-19 impact on multiple myeloma prescribing patterns. Dipti Shah, Kelly McAuliff, Elias Pittos, Amanda McCarthy, William Cavers, Rashmi Grover, et al. (+3)
114 [GO] 2022―Sep―30 A community hospital’s approach towards same-day discharge after minimally invasive hysterectomies during the COVID-19 pandemic. Christine Chien, Georgina Cheng
115 [GO] 2022―Sep―30 Patient-reported satisfaction with care and care coordination: Results from an online survey conducted in Manitoba, Canada during the COVID-19 pandemic. Maclean Harvey Thiessen, Kathleen Decker, Jason Park, Andrea Soriano
116 [GO] 2022―Sep―30 Racial/ethnic differences in telemedicine utilization and satisfaction among patients with breast cancer during the COVID-19 pandemic. Jincong Freeman, Fangyuan Zhao, Rita Nanda, Olufunmilayo I. Olopade, Dezheng Huo
117 [GO] 2022―Sep―30 Mammographic follow-up before and during the COVID-19 pandemic. Ritika Manik, Connor B. Grady, Sara Ginzberg, Christine E. Edmonds, Leisha C Elmore, Julia T Lewandowski, et al. (+2)
118 [GO] 2022―Sep―30 Staff experiences with remote work in a comprehensive cancer center during the COVID-19 pandemic. Christopher McChesney, Melanie Lynn Powis, Osvaldo Espin-Garcia, Lyndon Morley, Saidah Hack, Monika K. Krzyzanowska
119 [GO] 2022―Sep―30 Time to diagnosis and treatment initiation during the COVID-19 pandemic among rural patients with cancer. Izumi Okado, Michelle Liu-Duerr, Carry Elhajj, Randall F. Holcombe
120 [GO] 2022―Sep―30 Cancer treatment delays among patients with cancer living with HIV during the COVID-19 pandemic in the United States. Ashley Khouri, Jessica Yasmine Islam, Nathan Van Bibber, Anna Coghill, Gita Suneja
121 [GO] 2022―Sep―30 Impact of the COVID-19 pandemic on oral oncolytic adherence. Kelly McAuliff, Wilbur Rutter, William Cavers, Dipti Shah, Elias Pittos, Lucia Feczko, et al. (+3)
122 [GO] 2022―Sep―30 Impact of the COVID-19 pandemic on patient perceptions of the quality of their cancer care. Melanie Lynn Powis, Shabbir M.H. Alibhai, Alejandro Berlin, Rinku Sutradhar, Simron Singh, Saidah Hack, Monika K. Krzyzanowska
123 [GO] 2022―Sep―30 The effect of modifications to clinical trial activities implemented during the COVID-19 pandemic on willingness to participate in clinical trials: The TBCRC 057 survey. Karen L. Smith, Gina L. Mazza, Carolyn Mead-Harvey, Eileen H. Shinn, Elizabeth S. Frank, Michelle E. Melisko, et al. (+6)
124 [GO] 2022―Sep―30 Cost-of-care analysis between patients with cancer with COVID-19 utilizing a remote patient-monitoring program versus usual care. Joshua Pritchett, Nandita Khera, James P. Moriarty, Ruchita Dholakia, Tufia C. Haddad, Bijan J. Borah
125 [GO] 2022―Sep―30 Comorbidities among patients with breast cancer during COVID-19: Agreement between patient-reported data and electronic medical records. Martine C. Maculaitis, Xianchen Liu, Jeffrey A. Thompson, Alexandra Berk, Angelina Massa, Marisa C. Weiss, et al. (+3)
126 [GO] 2022―Sep―30 Virtual care beyond COVID-19: Patient and physician perspectives. Nazek Abdelmutti, Alejandro Berlin, Alyssa Macedo, Jackie Bender, Zhihui (Amy) Liu, Janet Papadakos, et al. (+7)
127 [GO] 2022―Jun―27 Longitudinal COVID-19 Vaccination-Induced Antibody Responses and Omicron Neutralization in Patients With Lung Cancer Philip C. Mack, Fred R. Hirsch, Paul A. Bunn, John D. Minna
128 [GO] 2022―Jun―27 Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant Rajesh M. Valanparambil, Jennifer Carlisle, Susanne L. Linderman, Akil Akthar, Ralph Linwood Millett, Lilin Lai, et al. (+33)
129 [GO] 2022―Jun―16 Evaluating Accuracy of Medical Information Distribution Regarding Risk of COVID-19 Infections and Childhood Cancer Survivors Wei Ling Lee, Kang-Hsi Wu, James Cheng-Chung Wei
130 [GO] 2022―Jun―08 Humoral and cellular immune response to Sars-CoV-2 wild-type and variants of concern following 3-dose vaccination in a large cohort of adults with cancer: The SerOzNET study. Eva Segelov, Amy Body, Vi Thi Thao Luong, Veronica Aedo Lopez, Luxi Lal, Hesham Abdulla, et al. (+9)
131 [GO] 2022―Jun―08 Patient-reported toxicity and quality of life following Sars-CoV-2 vaccination in adults and children with cancer. Amy Body, Claire Wakefield, Vi Thi Thao Luong, Mark Donoghoe, Noemi Auxiliadora Fuentes Bolanos, Antoinette Anazodo, et al. (+4)
132 [GO] 2022―Jun―06 Increased risk of venous thrombosis in breast cancer patients receiving chemotherapy treatment after COVID-19. Tatiana V. Ausheva, Oksana V. Katelnitskaya, Oleg I. Kit, Elena M. Frantsiyants, Liubov Yu Vladimirova, Viktoria R. Zakharchenko, et al. (+3)
133 [GO] 2022―Jun―06 #SurgOnc: Global discussions about surgical cancer care on Twitter during COVID-19. Sofia Gereta, Vishal R. Patel, Michael Mackert, Alex Bernard Haynes
134 [GO] 2022―Jun―06 Effect of anticancer therapy on mortality and COVID-19 severity in cancer patients with COVID-19. Phyo Thazin Myint, Aye Thet
135 [GO] 2022―Jun―06 Use of Merlin Assay to identify patients with a low-risk for SN metastasis in a prospective multicenter Dutch study of a primary melanoma gene-signature (CP-GEP model) to predict sentinel node status during COVID-19. Robert Stassen, Evalyn Mulder, Antoine Veringa, Antien Mooyaart, Jvalini Dwarkasing, Dennie Tempel, et al. (+6)
136 [GO] 2022―Jun―06 Real-world treatment patterns in patients with Sézary syndrome in the United States and the impact of Covid-19. Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Oleg Akilov
137 [GO] 2022―Jun―06 Presentation, management, and outcome of COVID-19 among patients with cancer in the Middle East and North Africa (MENA) region. Abdul-Rahman Jazieh, Hikmat Abdel-Razeq, Hakan Akbulut, Adda Bounedjar, Arafat H. Tfayli, Emad M Tashkandi, et al. (+14)
138 [GO] 2022―Jun―06 The impact of COVID-19 and armed conflict on cancer care in Armenia: A cross-sectional study. Yeva Margaryan, Liana Hambardzumyan, Tigran Aghabekyan, Gregory Peter Kalemkerian, Samvel Danielyan, Armen Muradyan, et al. (+2)
139 [GO] 2022―Jun―06 Clinical assessment of the Omicron outbreak in Europe and trends in morbidity and mortality from COVID-19 and cancer. Alessio Cortellini, Juan Aguilar-Company, Rachel Sharkey, Anna Sureda Balari, Alexia Francesca Bertuzzi, Joan Brunet, et al. (+14)
140 [GO] 2022―Jun―06 An update on the overall epidemiology, clinical characteristics, and outcomes from the COVID-19 and Cancer Consortium (CCC19). Dimpy P Shah, Pankil Shah, Jeremy Lyle Warner, Gerald Batist, Christopher Ryan Friese, Elizabeth A. Griffiths, et al. (+14)
141 [GO] 2022―Jun―06 COVID-19 in patients with gynecologic cancer: A preliminary report from the COVID-19 and Cancer Consortium (CCC19). Alicia Beeghly-Fadiel, Lauren S. Prescott, Erika Ruiz-Garcia, Clara Hwang, Hannah Heilman, Rana R. McKay, et al. (+12)
142 [GO] 2022―Jun―06 Clinical characteristics and outcomes of COVID-19 disease in patients with cancer. Muhammet Ozer, Suleyman Yasin Goksu, Mohammed Mahdi, Neel Jitendra Gandhi
143 [GO] 2022―Jun―06 COVID-19 impact on multiple myeloma prescribing patterns. Elias Pittos, Dipti Shah, Kelly McAuliff, Amanda McCarthy, William Cavers, Rashmi Grover, et al. (+3)
144 [GO] 2022―Jun―06 Mitigating the risk of COVID-19 in a large community oncology clinic and its impact on the patient experience. Ravnoor Kang, Rachel Dhir, Marco Iafolla, William Raskin, Shaan Dudani, Juhi Husain, et al. (+8)
145 [GO] 2022―Jun―06 Short and medium-term outcomes of patients with solid cancer hospitalized with COVID-19 in Belgium according to cancer diagnosis and treatment characteristics. Tatjana Geukens, Mariana Brandão, Marjolein Heijlen, Joelle Collignon, Cedric Van Marcke, Ingrid Louviaux, et al. (+9)
146 [GO] 2022―Jun―06 Outcome of cancer patients affected by COVID-19 in different settings. Ahmad El Mahmoud, Paul El-Meouchy, Nathalie Chamseddine, Elie Jean Karam, Wafaa Khaled, Youssef Zougheib, et al. (+7)
147 [GO] 2022―Jun―06 Racial/ethnic disparities of cancer treatment disruptions among patients with breast cancer with SARS-CoV-2 infection: An analysis of the ASCO Survey on COVID-19 in Oncology Registry. Jessica Yasmine Islam, Cassandra Hathaway, Kimberley T Lee, Emma Hume, Kea Turner, Julie E. Hallanger-Johnson, et al. (+2)
148 [GO] 2022―Jun―06 The role of rurality in cancer treatment disruptions among patients with cancer diagnosed with SARS-CoV-2: An analysis of the ASCO Survey on COVID-19 in Oncology Registry. Jessica Yasmine Islam, Kea Turner, Cassandra Hathaway, Emma Hume, Julie E. Hallanger-Johnson, Shelley Tworoger, Marlene Camacho-Rivera
149 [GO] 2022―Jun―06 The importance of the long Covid-19 in the evolution of patients with neoplasms. Viola Popov, Mihaela Andreescu, Catalina Pirvu, Andra Grigorie, Oana Constantin, Andreea Calen, et al. (+4)
150 [GO] 2022―Jun―06 Real-world use of mogamulizumab among patients with mycosis fungoides and Sézary syndrome before and during COVID-19 in the United States. Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Ahmad Sami Halwani
151 [GO] 2022―Jun―06 National claims data analysis of outcomes of hospitalized cancer patients without COVID-19 infection during versus prior to the COVID-19 pandemic. Jennifer Lee Caswell-Jin, Maryam Nemati Shafaee, Mina Liu, Lan Xiao, Esther M John, Melissa Bondy, Allison W. Kurian
152 [GO] 2022―Jun―06 Retrospective review of outcomes of patients with multiple myeloma with COVID-19 infection (two-center study). Hamid Ehsan, Alec Britt, Peter M. Voorhees, Barry Paul, Manisha Bhutani, Cindy Varga, et al. (+7)
153 [GO] 2022―Jun―06 The impact of COVID-19 lockdown measures on rates of febrile neutropenia in a cohort of Irish patients receiving chemotherapy. David Synnott, James Cook, Deirdre O'Mahony, Conleth G. Murphy
154 [GO] 2022―Jun―06 Sociodemographic trends in COVID-19 mortality in patients with cancer: A nationwide analysis. Sree Jambunathan, Jacob Lang, Malik Mays, Mersiha Hadziahmetovic, Oluchi Ukaegbu Oke, Obi Ekwenna
155 [GO] 2022―Jun―06 COVID-19 omicron variants demonstrated different virulence in infected patients with cancer: The real-world evidence from the National COVID Cohort Collaborative (N3C). Qianqian Song, Benjamin Bates, Fang-Chi Hsu, Feifan Liu, Vithal Madhira, Amit Kumar Mitra, et al. (+5)
156 [GO] 2022―Jun―06 Impact of COVID-19 on individuals with paraganglioma/pheochromocytoma history and/or hereditary risk. Samantha Greenberg, Nicholas Yozamp, Amanda Anson, Sarah Brand, Luke Buchmann, Wendy Kohlmann, et al. (+5)
157 [GO] 2022―Jun―06 The impact of COVID-19 on patients with cancer in the Oncology Care Model in the U.S. Oncology Network during performance period 8. Lalan S. Wilfong, Hope Ives, Puneeth Indurlal, Stuart Staggs, Judi Payne-De Bock, Marcus A. Neubauer
158 [GO] 2022―Jun―06 The longitudinal impact of COVID-19 on the diagnosis and treatment of lung cancer at a Canadian academic center: Interim analysis from a retrospective chart review. Angelo Rizzolo, Goulnar Kasymjanova, Carmela Pepe, Jennifer Elisabeth Friedmann, David I. Small, Colton Price-Gallagher, et al. (+8)
159 [GO] 2022―Jun―06 The impact of COVID-19 on the performance of the Rapid Access Lung Clinic: The Cork/Kerry experience. Colum Dennehy, Mohammad Javad Ghassemi Rad, Marcus Kennedy, Michael Henry, Dearbhaile Catherine Collins, Noreen Lyons, et al. (+2)
160 [GO] 2022―Jun―06 Feasibility of virtual stress management and resiliency training (SMART) for oncology fellows during the COVID-19 pandemic. Colt Williams, Sherry Chesak, Deirdre R. Pachman, Laura Rhee, Ross Dierkhising, Konstantinos Leventakos
161 [GO] 2022―Jun―06 Characterizing online engagement and academic impact of oncology research during the COVID-19 pandemic. Chandrasekar Muthiah, Arun Muthiah, Chapman Wei, Hina Khan
162 [GO] 2022―Jun―06 Assessing breast cancer screening results through the lens of COVID-19 pandemic. Dilyara Kaidarova, Alma Zhylkaidarova, Muratzhan Saktaganov
163 [GO] 2022―Jun―06 Risk-stratified FIT for urgent colonoscopy in Lynch syndrome: A clinical service throughout the COVID-19 pandemic. Anne G Lincoln, Sally C Benton, Peter Sasieni, Kevin J Monahan
164 [GO] 2022―Jun―06 Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic. Karin Purshouse, John P Thomson, Mahéva Vallet, Lorna Alexander, Isaac Bonisteel, Maree Brennan, et al. (+12)
165 [GO] 2022―Jun―06 Implementing proven methods in a community-based health system to improve breast cancer screening rates during the COVID-19 pandemic. Celine Fadel, Shivang Danak, Andria P Caton
166 [GO] 2022―Jun―06 Racial and socioeconomic disparities in telemedicine use among US patients initiating cancer treatment during the COVID-19 pandemic. Jenny Guadamuz, Xiaoliang Wang, Trevor Joseph Royce, Gregory Sampang Calip
167 [GO] 2022―Jun―06 Trends in low-value oncology care during the COVID-19 pandemic. Ravi Bharat Parikh, Yasin Civelek, Pelin Ozluk, David Joseph Debono, Michael Jordan Fisch, Gosia Sylwestrzak, et al. (+2)
168 [GO] 2022―Jun―06 A longitudinal study assessing the impact of ongoing COVID-19 pandemic among hematology-oncology trainees. Sufana Shikdar, Rabia Saleem, Joel Alcid, Sarbajit Mukherjee, Ayesha Hassan, Vinay E. Keshava, et al. (+2)
169 [GO] 2022―Jun―06 COVID-19 pandemic experience in patients with Hodgkin lymphoma. Sara E. Prischak, Hatcher J. Ballard, Adam N. Duca, James M. Gerson, Daniel J Landsburg, Stefan K. Barta, Jakub Svoboda
170 [GO] 2022―Jun―06 Decision making support for cancer patient's treatment strategy during the COVID-19 pandemic in Japan. Shiori Yoshida, Fumiko Sato, Konosuke Sasaki, Rie Sasaki
171 [GO] 2022―Jun―06 Telephone medical consultation during the COVID-19 pandemic in Mexico. Eduardo Rey Torres-Cisneros, Carla Renata Bruni-Guerrero, Juan Manuel Martínez-Valenciano, Rubi Janday Najera, Alan Ledif Reyes Mondragon, Yuridia Evangelina Rodríguez-Rodríguez, et al. (+7)
172 [GO] 2022―Jun―06 Trend analysis of effect of COVID-19 pandemic on breast cancer staging. Li Zhao, Vinit Singh, Farhan Khalid, Margaret Eng, Trishala Meghal
173 [GO] 2022―Jun―06 Multi-layered measures for mitigating effects of COVID-19 pandemic on national breast cancer screening programme. Miloš Vrhovec, Katja Jarm, Kristijana Hertl, Veronika Kutnar, Vesna Škrbec, Mateja Kurir Borovcic
174 [GO] 2022―Jun―06 Consequences of the COVID-19 pandemic on new cancer visits to a comprehensive cancer center in New York. Katherine Garcia, Abhinav Rohatgi, Chinyere Okpara, Megan Winner, Jeffrey S. Weber, Marc Justin Braunstein
175 [GO] 2022―Jun―06 Impact of the COVID-19 pandemic on stage at diagnosis of patients with breast cancer: An analysis of 11,752 patients from Oncoclínicas. Cristiano Augusto Andrade de Resende, Rodrigo Dienstmann, Carlos H. Barrios, Bruno Lemos Ferrari, Aline Coelho Goncalves, Fanny Cascelli, et al. (+10)
176 [GO] 2022―Jun―06 Patient-reported disruptions to cancer care in the U.S. during the COVID-19 pandemic: A national cross-sectional study. Sharanya Iyer, Jacob Lang, Aparna Narendrula, Kristine M. Zanotti, Puneet Sindhwani, Elias Mossialos, Obi Ekwenna
177 [GO] 2022―Jun―06 The effect of group psychotherapy on quality of life of cancer patients undergoing chemotherapy or endocrine therapy during Covid-19 pandemic: One center experience. Mariam Abuladze, Tamar Esakia, Tamta Cholikidze, Ketevani Barabadze, Khatuna Saganelidze
178 [GO] 2022―Jun―06 Shifting perceptions of alternative therapies in cancer patients during the COVID-19 pandemic: Results from the Complementary and Alternative Medicine Exposure in Oncology (CAMEO) Study. Christopher R. Weil, Ryan J. Hutten, Brandon M. Barney, Angela Fagerlin, David K. Gaffney, David Michael Gill, et al. (+8)
179 [GO] 2022―Jun―06 Clinical outcomes in COVID-19 patients with cancer who are treated with chemo- or immunotherapy. Haris Hatic, Jenny B Jung, Kristine Ria Hearld, Jessy Deshane, Devika Govind Das
180 [GO] 2022―Jun―06 Mortality and prognostic factors in hospitalized COVID-19 patients with cancer: An analysis from a large healthcare system in the United States. Meri Tarockoff, Luis E. Raez, Carlos Carracedo Uribe, Jianli Niu, Candice Sareli, Nithya Sundararaman, et al. (+3)
181 [GO] 2022―Jun―06 COVID-19 reduced the detection of lung cancer in first-time visitors, but not in repeated visitors in annual lung cancer screening. Tatsuo Kimura, Shinya Fukumoto, Akemi Nakano, Hideki Fujii, Yuji Nadatani, Shingo Takashima, et al. (+4)
182 [GO] 2022―Jun―06 The association of COVID-19 testing with cancer care disruption. John Panzone, Christopher Welch, Maximillian S Wu, Joseph M Jacob, Oleg Shapiro, Alina Basnet, et al. (+2)
183 [GO] 2022―Jun―06 Tackling healthcare inequities through a social media-based platform to connect solid tumor patients with COVID-19 to clinical trials. Yan Leyfman, Samarth Sandeep, Kirk McGregor, Peter Rizk, Carlo Khoury, Chandler H. Park
184 [GO] 2022―Jun―06 Real-life trends of COVID-19 vaccination and outcomes among patients with cancer in Georgia: One center experience. Tamar Esakia, Nino Balanchivadze, Ana Makashvili, Mariam Abuladze, Margarita Kacharava, Tamar Melkadze, et al. (+5)
185 [GO] 2022―Jun―06 Longitudinal immunological responses of COVID-19 vaccination in patients with solid tumors on active treatment: A pilot study. Lifen Cao, Shelby Rose Kopp, Patricia A. Rayman, Naji Mallat, Yan Leyfman, James Michael Martin, et al. (+3)
186 [GO] 2022―Jun―06 COVID-19 vaccination status and clinical outcomes in solid cancer patients treated with immune checkpoint inhibitors. Karam Khaddour, Natalie Meeder, Josette Mary Kamel, Amaara Babwah, Ryan Huu-Tuan Nguyen, Heidy Wang, et al. (+4)
187 [GO] 2022―Jun―06 The safety assessment of COVID-19 vaccine injection in patients with colorectal cancer. FangFang Wei, Jun Huang, Lihua Huang, Fengyun Pei, Meijin Huang
188 [GO] 2022―Jun―06 Socioeconomic status for predicting COVID-19-related changes in cancer prevention behaviors. Mohamed I. Elsaid, Xiaochen Zhang, Cecilia DeGraffinreid, Electra D. Paskett
189 [GO] 2022―Jun―06 Altered cancer care delivery during COVID-19: Evaluating the impact of virtual clinics and treatment changes on oncology patient outcomes, quality of life, and satisfaction. Jacob Kachura, Adriyan Hrycyshyn, Alexandria Abbruzzino, Adam Deruchie Tan, Janet Smith, Christine Brezden
190 [GO] 2022―Jun―06 Preliminary outcomes for non-metastatic breast cancer before and during the coronavirus disease 2019 pandemic at community cancer centers. Fangzheng Yuan, Ahmed Abdelhakeem, Samantha Blevins, Chelsey Peters, Susan E. Whalen, Ernest Clayton Hymel
191 [GO] 2022―Jun―06 Antibody seroprevalence against SARS-Cov-2 among chronic myeloid leukemia patients. Marisol Miranda, Danielle Bradshaw, Jaspreet Farmaha, Reeya Patel, Kimya Jones, Harmanpreet Singh, et al. (+4)
192 [GO] 2022―Jun―06 Clinical impact of SARS-CoV-2 delta variant infection in tumor patients and the impact of vaccination on different cancer treatment regimens. Louisa Hempel, Armin Piehler, Beate Gandorfer, Julia Veloso de Oliveira, Patrick Philipp, Sebastian Robert, et al. (+10)
193 [GO] 2022―Jun―06 Post-acute sequelae of SARS-CoV-2 infection in patients with cancer. Jeremy Lyle Warner, David J. James Pinato, Sanjay Mishra, Renee Maria Saliby, Clara Hwang, Shuchi Gulati, et al. (+14)
194 [GO] 2022―Jun―06 Impaired seroconversion after SARS-COV-2 mRNA vaccine in patients with thymic epithelial tumors. Erica Pietroluongo, Pietro De Placido, Rocco Morra, Margaret Ottaviano, Marianna Tortora, Mariarosaria Saponaro, et al. (+13)
195 [GO] 2022―Jun―06 Adverse drug reactions of the SARS-CoV-2 mRNA-1273 vaccine in a cohort of cancer patients of a tertiary hospital in Madrid, Spain. Alejandro Francisco Jiménez Ortega, Alicia de Luna Aguilar, Javier David Benitez Fuentes, Paloma Flores Navarro, Elvira Baos Muñoz, Alberto Delgado-Iribarren García-Campero, et al. (+5)
196 [GO] 2022―Jun―06 Trends in cancer diagnosis during the SARS-CoV-2 pandemic. Tamara Lynne Bautista Aqui, Andrew Hwang, Napatkamon Ayutyanont, Erica Junqueira
197 [GO] 2022―Jun―06 Attitude towards and experience with SARS-CoV-2 vaccination among German cancer patients. Oliver Overheu, Simon Lendowski, Corinna Sophie Marheinecke, Daniel R. Quast, Eleni Kourti, Celine Lugnier, et al. (+3)
198 [GO] 2022―Jun―06 Booster third dose of SARS-CoV-2 vaccine effectively lifts the waning immune response of solid cancer patients. Urska Janzic, Urska Bidovec-Stojkovic, Mohorcic Katja, Nina Fokter Dovnik, Marina Caks, Jerneja Debeljak, et al. (+2)
199 [GO] 2022―Jun―06 Clinical effectiveness of SARS-CoV-2 vaccines and booster doses in patients with cancer: An analysis from the European OnCovid registry. David J. James Pinato, Juan Aguilar-Company, Daniela Ferrante, Georgina Helen Hanbury, Mark Bower, Ramon Salazar, et al. (+14)
200 [GO] 2022―Jun―06 Outcome of follicular lymphoma (FL) patients in maintenance with antiCD20 monoclonal antibodies (MoAb) in SARS-Cov2 era. Alessia Castellino, Claudia Castellino, Carola Boccomini, Michele Clerico, Paolo Nicoli, Anna Vanazzi, et al. (+14)
201 [GO] 2022―Jun―06 Will COVID-19 directives to reduce regularly scheduled physical examinations affect recurrence detection in patients with early breast cancer? Ana-Alicia Beltran-Bless, Bader Alshamsan, Mashari J. Alzahrani, John Frederick Hilton, Vicky Samuel, Kelly-Anne Baines, et al. (+4)
202 [GO] 2022―Jun―06 Increased incidence of immune-mediated myocarditis in advanced skin malignancies treated with immune checkpoint inhibitors in the COVID-19 era. Allison Gradone, Vincent T Ma, Leslie Anne Fecher, Sarah Elizabeth Yentz, Alexi Vasbinder, Salim S. Hayek, Christopher D. Lao
203 [GO] 2022―Jun―06 The impact of COVID-19 infection on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors. Mengni Guo, Jieying Liu, Zohaib Ahmed, James Yu, Ruoyu Miao, Jian Guan, et al. (+6)
204 [GO] 2022―Jun―06 COVID-19 infections among minority patients with gastrointestinal malignancies in urban safety net academic medical centers. Radhika Gali, Mariuxi Alexandra Viteri Malone, Sanjay Goel
205 [GO] 2022―Jun―06 Rapidly adapting the clinical research environment at an NCI-designated comprehensive cancer center to the COVID-19 pandemic. Andrew B. Lassman, Frances L. Brogan, Ryan J. Shelton, Edward Bentlyewski, Moshe A. Kelsen, Helen Kim, et al. (+3)
206 [GO] 2022―Jun―06 Treatment patterns and outcomes of patients with high-grade glioma during the COVID-19 pandemic. Manik Chahal, Ghufran Abdulghaffar Aljawi, Rebecca A. Harrison, Alan Nichol, Brian Arthur Thiessen
207 [GO] 2022―Jun―06 The impact of virtual oncology care on chemotherapy continuity and clinical outcomes in patients treated for colorectal cancer: A pre-post analysis of the COVID-19 pandemic. William James Phillips, Macyn Leung, Kednapa Thavorn, Timothy R. Asmis
208 [GO] 2022―Jun―06 Preliminary analysis of an expanded access study of the fixed-dose combination of pertuzumab (P) and trastuzumab (H) for subcutaneous injection (PH FDC SC) for at-home administration (admin) in patients (pts) with HER2-positive (HER2+) breast cancer (BC) during the COVID-19 pandemic. Chau T. Dang, Sara M. Tolaney, Fauzia Riaz, Antoinette R. Tan, Katherine H. R. Tkaczuk, Anthony Francis Yu, et al. (+5)
209 [GO] 2022―Jun―06 Time to biopsy of screening mammography-detected abnormalities: Evaluating the impact of same-day services implemented during the COVID-19 pandemic. Kimberly Klinger, Brian Dontchos, Sarah Mercaldo, Janeiro Achibiri, Gary Wang, Randy Miles, et al. (+2)
210 [GO] 2022―Jun―06 The role of telemedicine in care of patients with cancer: A real-world experience from a Peruvian cancer institute during the COVID-19 pandemic. Katia Roque Perez, Rossana Ruiz, Iris Otoya, Tatiana Vidaurre, Jose Galarreta, Ramon Andrade De Mello, et al. (+3)
211 [GO] 2022―Jun―06 Hematology/oncology outpatient perspectives on telehealth one year into the COVID-19 pandemic. Anne Hudson Blaes, Patricia Jewett, Shernan Holtan, Bruce Lindgren, Jane Hui, Alexander Albert Boucher
212 [GO] 2022―Jun―06 Responses to telehealth expansion for older adults with cancer during the COVID-19 pandemic. Robin T Higashi, Bella Etingen, Suzanne Cole, John C. Mansour, John W. Sweetenham, Jessica L. Lee, Timothy P. Hogan
213 [GO] 2022―Jun―06 Telehealth delivered Tai Chi intervention for managing aromatase inhibitor-induced arthralgia in breast cancer patients: TaiChi4Joint during the COVID-19 pandemic a Pilot study. Sameh Gomaa, Carly West, Ana Maria Lopez, Tingting Zhan, Max Schnoll, Maysa M. Abu-Khalaf, et al. (+2)
214 [GO] 2022―Jun―06 Imaging and physician visits at cancer diagnosis: COVID-19 pandemic impact on cancer care. Rui Fu, Rinku Sutradhar, Qing Li, Timothy Hanna, Kelvin K. Chan, Natalie Coburn, et al. (+2)
215 [GO] 2022―Jun―06 Telemedicine adoption and utilization among financially distressed patients with cancer during the COVID-19 pandemic: Insights from a longitudinal nationwide survey. Abbas Hassan, Carrie K. Chu, Jun Liu, Rebekah Angove, Gabrielle Betty Rocque, Kathleen D. Gallagher, et al. (+6)
216 [GO] 2022―Jun―06 A prospective ultrasonographic surveillance study on the incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy following a booster shot. Kumiko Kida, Hiroko Tsunoda, Risa Kasahara, Chie Hirai, Akiko Numata, Yuri Takehara, et al. (+6)
217 [GO] 2022―Jun―06 Immunogenicity of the vaccine against Sars-Cov-2 in cancer patients under active treatment. María Leonor Fernandez-Murga, Lucia Serrano-Garcia, Javier Garde-Noguera, Maria Portero, José García-Sánchez, Lorena Regal, et al. (+2)
218 [GO] 2022―Jun―06 Clinical outcome and characteristics of Turkish breast cancer patients during SARS-Cov-2 pandemic: Single center experience. Aysun Isıklar, Aykut Soyder, Ozge Gumusay, Gul Basaran
219 [GO] 2022―Jun―06 Digital patient-reported outcomes and serological response to SARS-COV-2 vaccines in patients with cancer. Jose L. Sandoval, Sebastien Bugeia, Santeri Mentu, Garance Gutknecht, Jussi Ekström, Anna Battagin, et al. (+6)
220 [GO] 2022―Jun―06 Diagnoses, treatment, and utilization changes in oncology patients before and during COVID-19. Miao Wang, Sylvie Lardeux, Elisea Avalos-Reyes, Kjel Andrew Johnson
221 [GO] 2022―Jun―06 COVID-19 outcomes in patients with cancer and HIV: An analysis of the COVID-19 and Cancer Consortium (CCC19). Suki Subbiah, Jessica Yasmine Islam, Cassandra Hennessy, Jun Yang Jiang, Sharad Goyal, Diana Vilar-Compte, et al. (+14)
222 [GO] 2022―Jun―06 Breakthrough COVID-19 cases and hospitalization risk: ASCO COVID-19 registry. Suanna Steeby Bruinooge, Dax Kurbegov, Melinda Kaltenbaugh, Jen Hanley Hanley Williams, Julie R. Gralow, Elizabeth Garrett-Mayer
223 [GO] 2022―Jun―06 Major risk factors associated with severe COVID-19 outcomes in patients with multiple myeloma: Report from the National COVID-19 Cohort Collaborative (N3C). Amit Kumar Mitra, Ujjal Mukherjee, Suman Mazumder, Vithal Madhira, Timothy Bergquist, Yu Shao, et al. (+6)
224 [GO] 2022―Jun―06 Functional activity of peripheral blood mononuclear cells in patients with non-Hodgkin's lymphomas receiving treatment after COVID-19 disease. Aleksandr B. Sagakyants, Irina B. Lysenko, Oksana G. Shulgina, Inna A. Kamaeva, Ekaterina I. Zolotareva, Inna A. Novikova, et al. (+6)
225 [GO] 2022―Jun―06 Characteristics and outcomes of COVID-19 in adult cancer patients: Tertiary cancer center experience. Hazim Ababneh, Fadwa Alqadi, Mohammad Ma'koseh, Khalid Halahleh, Layan Abo abed, Mohammad Akkawi, et al. (+2)
226 [GO] 2022―Jun―06 The COVID-19 in oncological settings: The buffering role of the physician’s empathic communication protects from the impact of fear on hopelessness. Alessandro Rossi, Maria Marconi, Federica Taccini, Stefania Mannarini, Claudio Verusio
227 [GO] 2022―Jun―06 Smoking and COVID-19 in patients with cancer: Novel analysis from CCC19 registry. Amit Kulkarni, Cassandra Hennessy, Grace Wilson, Vidhyalakshmi Ramesh, Clara Hwang, Joy Awosika, et al. (+13)
228 [GO] 2022―Jun―06 Long COVID-19 in patients with cancer: Report from the National COVID Cohort Collaborative (N3C). Noha Sharafeldin, Vithal Madhira, Qianqian Song, Benjamin Bates, Amit Kumar Mitra, Feifan Liu, et al. (+4)
229 [GO] 2022―Jun―06 Impact of COVID-19 on risk of venous thromboembolism (VTE) in cancer patients: A single institution analysis. Aneesha Ananthula, Katharine Thomas, Dat Tran, Anh Nguyen, Katie Lauren McLemore McQueen Amaker, Brandon T Thrash, et al. (+5)
230 [GO] 2022―Jun―06 The FLARE score, circulating neutrophils, and association with COVID-19 outcomes in patients with solid tumors. Elia Seguí, Edouard Auclin, Juan Manuel Torres, David Casadevall, Juan Aguilar-Company, Marta Rodríguez, et al. (+14)
231 [GO] 2022―Jun―06 Integration of geriatric assessment in cancer care for senior adults during COVID-19 pandemic. Mohammed Al-Jumayli, Cassandra Vonnes, Marina Sehovic, Martine Extermann
232 [GO] 2022―Jun―06 Evaluation of social connectedness, loneliness, and anxiety among cancer survivors during the 2020-2021 winter surge of COVID-19 pandemic. Hermine Poghosyan, James B. Yu
233 [GO] 2022―Jun―06 Associations between cancer history, social distancing behaviors, and loneliness in adults during the COVID-19 pandemic. Jenny Yang, Xiaochen Zhang, Ivy Yu, James L. Fisher, Cecilia DeGraffinreid, Electra D. Paskett
234 [GO] 2022―Jun―06 Experiences of researchers fulfilling VHA’s “fourth mission” during the COVID-19 pandemic. Kenneth Csehak, Alexander Michael Barbaro, Stefanie D. Roman, Scott Sherman, Danil V. Makarov, Sahnah Lim, Daniel Jacob Becker
235 [GO] 2022―Jun―06 Patient-reported distress at a cancer center during the COVID-19 pandemic. Manan P Shah, Sarah Rosenthal, Mohana Roy, Ali Raza Khaki, Tina Hernandez-Boussard, Kavitha Ramchandran
236 [GO] 2022―Jun―06 Capecitabine for advanced biliary tract cancers during COVID-19 pandemic. Chandan Krushna Das, T D Yadav, Harjeet Singh
237 [GO] 2022―Jun―06 TBCRC 057: An online survey about anxiety and willingness to participate in breast cancer clinical trials during the COVID-19 pandemic. Karen L. Smith, Gina L. Mazza, Carolyn Mead-Harvey, Eileen H. Shinn, Elizabeth S. Frank, Michelle E. Melisko, et al. (+6)
238 [GO] 2022―Jun―06 Breast cancer screening and diagnosis in a community health system during the COVID-19 pandemic. Andrew Rudberg, Bret Edward Buckley Friday, Catherine McCarty, Paula Termuhlen, Sam Friedrichsen, Sara Richter
239 [GO] 2022―Jun―06 Changes in cancer-related mortality during the COVID-19 pandemic in the United States. Jingxuan Zhao, Xuesong Han, Kimberly Miller, Zhiyuan Zheng, Leticia M. Nogueira, Farhad Islami, et al. (+2)
240 [GO] 2022―Jun―06 Has the COVID-19 pandemic lead to an upshift in emergency presentation and stage migration of colorectal cancer in Uruguay? Santiago Fontes, Megan Berry, Ana Marín-Jiménez, Juan Carlos Sánchez, Andrea Schiavone, Gabriel David Krygier, Mauricio Cuello
241 [GO] 2022―Jun―06 Impact of the COVID-19 pandemic on cervical cancer diagnosis and treatment in Botswana. Katharine A. Rendle, Tara Friebel-Klingner, Priya M Puri, Gauthami Moorkanat Gopakumar, Barati Monare, Tlotlo Ralefala, et al. (+5)
242 [GO] 2022―Jun―06 National impact of the COVID-19 pandemic on clinical trial staff attrition: Results of the SWOG Cancer Research Network Survey of Oncology Research Professionals. Don S. Dizon, Connie M. Szczepanek, Daniel P. Petrylak, Dana B. Sparks, Catherine Tangen, Primo "Lucky" N. Lara, et al. (+2)
243 [GO] 2022―Jun―06 Impact of the COVID-19 pandemic on colorectal cancer (CRC) care: Data from 22 German cancer centers (CC) and the Institute of Pathology, Ruhr-University Bochum - the AIO (Working Group for Internal Oncology of the German Cancer Society) CancerCOVID Consortium - AIO-YMO/KRK 520/ass. Celine Lugnier, Sarah Foerster, Anna-Lena Kraeft, Inke Sabine Feder, Jens Christmann, Eleni Kourti, et al. (+14)
244 [GO] 2022―Jun―06 Impact COVID-19 pandemic on lung cancer care from screening to postoperative follow-up. Isabel M Emmerick, Kevin Dickson, Olivia Sears, Keren Guiab, Bryce Bludevich, Maggie M. Powers, et al. (+3)
245 [GO] 2022―Jun―06 Impact of the COVID-19 pandemic on oral oncolytic adherence. Elias Pittos, Wilbur Rutter, William Cavers, Dipti Shah, Kelly McAuliff, Lucia Feczko, et al. (+3)
246 [GO] 2022―Jun―06 Impact of an interdisciplinary goals of care program on hospital outcomes at a comprehensive cancer center during the COVID-19 pandemic: A propensity score analysis. David Hui, Nico Nortje, Marina C. George, Kaycee Wilson, Diana L. Urbauer, Caitlin Lenz, et al. (+13)
247 [GO] 2022―Jun―06 Racial and ethnic disparities in lifestyle changes during the COVID-19 pandemic: Exploring the socioeconomic and psychosocial mechanisms. Ming Wen, David Curtis, Donglan Zhang, Zhuo Chen, Lu Shi, Liwen Chen, et al. (+7)
248 [GO] 2022―Jun―06 Change in breast cancer risk perception related to perceived COVID-19 risk: A WISDOM sub-population analysis. Tina Qing Huang, Ryan Baxter-King, Arash Naeim, Aaron Rudkin, Lynn Vavreck, Karen Sepucha, et al. (+3)
249 [GO] 2022―Jun―06 Seroconversion following first and second dose of COVID-19 vaccination among cancer patients: A prospective longitudinal observational study from India on the effectiveness of COVID vaccines. Krishnamani Iyer Kalpathi, Raj Kishore Pappala, Ayesha Nawaz, Mithra Krishnamani, Kavita Mathi
250 [GO] 2022―Jun―06 Patients' perspectives and safety of COVID-19 vaccination among cancer patients: A prospective single-center study. Nathalie Daaboul, Melina Boutin, Catherine Sperlich, Margit Fuchs, Louis-Patrick Haraoui, Giovanna Speranza, et al. (+11)
251 [GO] 2022―Jun―06 Impact of cancer diagnosis, stage, and systemic therapies on immunogenicity after COVID-19 vaccination in patients with cancer: A systematic review and meta-analysis. Guilherme Nader Marta, Chloe Spilleboudt, Diogo Martins-Branco, Ana Tecic Vuger, Veronique Debien, Lieveke Ameye, et al. (+7)
252 [GO] 2022―Jun―06 COVID-19 vaccine and incidence of severe immune-mediated adverse events in patients with renal cell carcinoma (RCC) on checkpoint inhibitor immunotherapy (CPI). Danielle Gilbert, Junxiao Hu, Elizabeth R Kessler, Elaine T. Lam
253 [GO] 2022―Jun―06 COVID-19 vaccine humoral response and treatment effect in patients with hematologic malignancy. Alex Hillyer, Jordan Spradbrow, Michael J Knauer, Jenny Kim, Anthony Quint, Selay Lam, et al. (+14)
254 [GO] 2022―Jun―06 COVID-19 vaccine uptake in patients with cancer and Sars-Cov-2 infection in 2020: Results from the ASCO registry. Jen Hanley Hanley Williams, Suanna Steeby Bruinooge, Melinda Kaltenbaugh, Julie R. Gralow, Elizabeth Garrett-Mayer
255 [GO] 2022―Jun―06 Evaluation of the use of COVID-19 vaccines in patients treated with immunotherapy. Yun Man, Garrett Rompelman, Angela Chen, Anita Giobbie-Hurder, Elizabeth Iannotti Buchbinder
256 [GO] 2022―Jun―06 Treatment with anti-spike monoclonal antibodies in allogeneic HCT and CAR T-cell recipients with mild to moderate COVID-19: The Mayo Clinic experience. Razan Mohty, Matthew Thoendel, Samuel Swei, Radhika Bansal, Jeanne Palmer, William J. Hogan, et al. (+11)
257 [GO] 2022―Jun―06 PD1 inhibition effect on immunization with MRNA vaccines against SARS-CoV-2. Martin Majer, Justin Knoefler, Elizabeth Fauchier Little, Megan Powell, Edward J. Ordorica, Roxanna Arakozie, et al. (+13)
258 [GO] 2022―Jun―06 Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for patients with breast cancer: A multicenter, prospective, observational study. Mitsuo Terada, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Yasuaki Uemoto, et al. (+10)
259 [GO] 2022―Jun―06 Use of quality-of-life-related (QoL) eHealth interventions with Latino cancer patients during the pandemic: Findings from Latin America, United States, and Spain. Rosario Costas-Muñiz, Cristiane Decat Bergerot, Eida M Castro-Figueroa, Oscar Galindo, Fernanda Montana, Loida Esenarro, et al. (+5)
260 [GO] 2022―Apr―18 Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Andres Chang, Akil Akhtar, Susanne L. Linderman, Lilin Lai, Victor M. Orellana-Noia, Rajesh Valanparambil, et al. (+19)
261 [GO] 2022―Mar―14 Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative Qianqian Song, Benjamin Bates, Yu Raymond Shao, Fang-Chi Hsu, Feifan Liu, Vithal Madhira, et al. (+7)
262 [GO] 2022―Feb―28 Risk of COVID-19 Infections and of Severe Complications Among Survivors of Childhood, Adolescent, and Young Adult Cancer: A Population-Based Study in Ontario, Canada Sumit Gupta, Rinku Sutradhar, Sarah Alexander, Michelle Science, Cindy Lau, Chenthila Nagamuthu, et al. (+3)
263 [GO] 2022―Feb―16 Effect of androgen receptor directed therapy in prostate cancer patients with COVID-19. Serhan Unlu, Junghee Jenny Shin, Jennefer Par-Young, Joseph Vinetz, Daniel P. Petrylak, Insoo Kang, Joseph W. Kim
264 [GO] 2022―Feb―16 Impact of COVID-19 on cancer caregivers: Results from the Global Carer Well-being Index. Karen V.L. Turpin, Elizabeth Foland, Taylor Patton, Jeremy Guterl, Marni Zapakin, Jasmine Greenamyer
265 [GO] 2022―Feb―16 Impact of COVID-19 on the incidence of prostate cancer among White and Black Veterans. Kyung Min Lee, Kripa Guram, Patrick Alba, Tori Anglin-Foote, Brian Robison, Brent S Rose, Julie Ann Lynch
266 [GO] 2022―Feb―16 Temporal changes in the screening, diagnosis and surgical treatment of genitourinary (GU) malignancies during the COVID-19 pandemic. Chris Labaki, Andrew Lachlan Schmidt, Ziad Bakouny, Muhieddine Labban, Talal El Zarif, Steven Lee Chang, et al. (+5)
267 [GO] 2022―Feb―16 The effect of anti-cancer therapy on immunological response to COVID-19 vaccination. Francesca Jackson-Spence, Charlotte Toms, Yu-Hsuen Yang, Lani Walshaw, Anna Riddell, Maria-Teresa Cutino-Moguel, et al. (+3)
268 [GO] 2022―Feb―16 Waning efficacy of COVID-19 vaccination at six months in patients (pts) with genitourinary malignancies. Zeynep Busra Zengin, Luis A Meza, Jasnoor Malhotra, Sabrina Salgia, Jennifer Ely, Joann Hsu, et al. (+14)
269 [GO] 2022―Jan―19 COVID-19 impact on diagnosis and staging of colorectal cancer: A single tertiary Canadian oncology center experience. Mathias Castonguay, Corentin Richard, Marie-France Vachon, Rami Mohamad Nassabein, Danielle Charpentier, Mustapha Tehfe
270 [GO] 2022―Jan―19 A multi-institutional study of the impact of the COVID-19 pandemic on pancreatic cancer diagnosis and management. Claudia Rosso, Jennifer B. Valerin, Parisa Oviedo, Niloofar Radgoudarzi, Wen-Pin Chen, Christine E. McLaren, et al. (+2)
271 [GO] 2022―Jan―19 Impact of the COVID-19 pandemic on primary care access for patients with gastrointestinal malignancies. Ying Ling, Kelvin K. Chan, Aditi Patrikar, Ning Liu, Aisha Lofters, Colleen Fox, et al. (+2)
272 [GO] 2022―Jan―19 COVID-19 vaccination in gastrointestinal cancer patients receiving chemotherapy: A single institute experience. Mitsukuni Suenaga, Shinichi Yamauchi, Taiki Masuda, Marie Hanaoka, Noriko Iwata, Yuya Sato, et al. (+3)
273 [GO] 2022―Jan―19 Lower COVID-19 vaccination rates amongst Australians with gastrointestinal (GI) compared to other cancers. Mike Nguyen, Nathan Bain, Lisa Grech, Nada Hamad, Bryan Anthony Chan, Richard Blennerhassett, et al. (+10)
274 [GO] 2022―Jan―19 Patient care satisfaction and emergency room utilization among young adult colorectal cancer survivors during the SARS-CoV-2 pandemic. Dalia Kagramanov, Kimberly Ann Miller, Phuong Gallagher, David R. Freyer, Joel Milam, Heinz-Josef Lenz, Afsaneh Barzi
275 [GO] 2021―Nov―09 Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study Vivek Naranbhai, Claire A. Pernat, Alexander Gavralidis, Kerri J. St Denis, Evan C. Lam, Laura M. Spring, et al. (+40)
276 [GO] 2021―Oct―25 SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities Emily E. Johnston, Isaac Martinez, Elizabeth S. Davis, Caroline Caudill, Joshua Richman, Julienne Brackett, et al. (+8)
277 [GO] 2021―Oct―08 Reasons to Consider the COVID-19 Vaccination Status of Patients With Cancer When Analyzing Their COVID-19 Outcomes Kazuki Takada, Shinkichi Takamori, Naoko Miura, Yasunori Shikada, Mototsugu Shimokawa
278 [GO] 2021―Sep―21 The impact of COVID-19 on breast cancer care: Delays in screening. Amina Dhahri, Teshome Tegene
279 [GO] 2021―Sep―21 Implementation of a novel patient-reported outcomes measure for patients with cancer and COVID-19 infection. Ishwaria Mohan Subbiah, Tito R. Mendoza, Xuetao Lu, Yanhong Zhou, J. Jack Lee, Feng Zhang, et al. (+8)
280 [GO] 2021―Sep―21 Trends in diagnosis and treatment of early breast cancer (eBC) in the United States (US) during the COVID-19 era. Benjamin Ackerman, Catherine Keane, Julia A. Beaver, Paul Gustav Kluetz, Donna Rivera, Prashni Paliwal, et al. (+4)
281 [GO] 2021―Sep―21 Association of lung cancer incidence and COVID-19 case fatality with income level in Ohio. Rohan Desai, Raoul Wadhwa, Jacob Scott
282 [GO] 2021―Sep―21 COVID-19 and advance care planning: A unique opportunity. Aliya Gessling, Mary Rank, Deborah Larson, Ann Soloway, Jessica Langston, Quy Tran
283 [GO] 2021―Sep―21 Assessing financial toxicity in patients with metastatic breast cancer: A single institution experience during the COVID-19 pandemic. Shruti Sinkar, Faith Too, Kelly Carr, Jessica Jelinek, Elizabeth Saylor, Jacqueline Bacon, et al. (+2)
284 [GO] 2021―Sep―21 Swabs by emergency responders (SWABBER): Enhancing care beyond the cancer center during the COVID-19 pandemic. Olivia S. Allen, Mark Liu, Kevin Munjal, Rex Lomboy, Aarti Sonia Bhardwaj, Alma Abdallah, et al. (+3)
285 [GO] 2021―Sep―21 Social determinants of health and the Barrio Advantage among Hispanics during the COVID-19 pandemic. Nerea Lopetegui-Lia, Jasmin Hundal, Katarina Bade, Emily Hsu, Jyoti Chhabra, Oscar Serrano, Alvaro G. Menendez
286 [GO] 2021―Sep―21 Satisfaction with and recommendations to improve telehealth visits among adolescents and young adults with cancer during the COVID-19 pandemic. Maria Chang Swartz, Michael Roth, Goldy George, J. Andrew Andrew Livingston, Stephanie J. Wells, Clark Andersen, et al. (+2)
287 [GO] 2021―Sep―21 Adoption of telemedicine (Telemed) by medical oncologists/hematologists (mO/H) during the COVID-19 pandemic. Yolaine Jeune-Smith, Gorica Malisanovic, Bruce A. Feinberg, Ajeet Gajra
288 [GO] 2021―Sep―21 Evaluating changes in “good safety monitoring” for cancer clinical trial participants during the COVID-19 pandemic. Meera Vimala Ragavan, Alyssa LaLanne, Andrea Skafel, Julian C. Hong, Anobel Y. Odisho, Sasha Yousefi, et al. (+2)
289 [GO] 2021―Sep―21 Changes in systemic cancer therapy prior-authorization requests during the COVID-19 pandemic. Helen Parsons, Jingxuan Zhao, Arjun Gupta, Henry J. Henk, K. Robin Yabroff
290 [GO] 2021―Sep―21 Satisfaction of hem/onc patients with video visits during the COVID-19 pandemic at a tertiary care center in Michigan. Fawzi Abu Rous, Sunny R K Singh, Pin Li, Mohamed Elgamal, Hussna Abunafeesa, Rebecca Chacko, et al. (+3)
291 [GO] 2021―Sep―21 Disruptions in cancer screening and diagnoses during the COVID-19 pandemic in 2020. James Staib, Kierstin Catlett, Stacey DaCosta Byfield
292 [GO] 2021―Sep―21 Breast cancer patients therapeutic adherence during the COVID-19 pandemic in Indonesia: Knowledge level analytical study. Widyanti Soewoto
293 [GO] 2021―Sep―21 Stage at cancer diagnosis during the COVID-19 pandemic in western Washington state. Catherine R. Fedorenko, Karma L. Kreizenbeck, Li Li, Laura Elizabeth Panattoni, Veena Shankaran, Scott David Ramsey
294 [GO] 2021―Sep―21 Impact of COVID-19 pandemic on oncologists’ professional and personal lives: A pre-vaccine study. Ajeet Gajra, Yolaine Jeune-Smith, Stephanie Fortier, Bruce A. Feinberg
295 [GO] 2021―Sep―21 The impact of the COVID-19 pandemic on patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) in an Australian outpatient oncology setting. Kate Webber, Olivia Cook, Michelle White, Alastair Kwok, Eva Segelov
296 [GO] 2021―Sep―21 Maintaining access to genomic cancer risk assessment (GCRA) during the COVID-19 pandemic using telemedicine in a resource-limited setting. Yanin Chavarri Guerra, Maria Fernanda Ochoa Chavez, Andrés Rodríguez-Faure, Alfredo Pherez Farah, Enrique Soto Perez De Celis, Danielle Castillo, et al. (+2)
297 [GO] 2021―Sep―21 Care at the end of life during the COVID-19 pandemic: A CancerLinQ Discovery (CLQD) analysis. Gabrielle Betty Rocque, Mark Riffon, Electra D. Paskett, Abdul-Rahman Jazieh, Jennifer C. King, Danielle M. Potter
298 [GO] 2021―Sep―21 Disparities in cancer care delivery during the COVID-19 pandemic: An update of a prospective, cross-sectional study. Emily Hsu, Jyoti Chhabra, Oscar Serrano, Katarina Bade, Alvaro G. Menendez
299 [GO] 2021―Sep―21 Safety and efficacy of COVID-19 vaccination in patients receiving systemic anticancer therapy. Mahir Khan, Ryan Huu-Tuan Nguyen, James Love, Alexander Krule, Michael Weinfeld, Kristy Abraham, et al. (+6)
300 [GO] 2021―Sep―21 Association of fear of COVID-19 with delays in care or treatment interruptions in patients with cancer. Karen L. Smith, Nicole E. Caston, Valerie Lawhon, Kathleen D. Gallagher, Rebekah Angove, Eric Anderson, et al. (+4)
301 [GO] 2021―Sep―21 Effect of COVID-19-related reductions in cancer screening in Native Hawaiians and across urban and rural communities in Hawaii. Randall F. Holcombe, Jeff Tom, Michael Morimoto, Elizabeth Wright, Izumi Okado, Anamalia Su'esu'e, Ian Pagano
302 [GO] 2021―Sep―21 Fear of COVID-19: Effects on mental health in under-resourced patients with cancer. Valerie Lawhon, Nicole E. Caston, Karen L. Smith, Kathleen D. Gallagher, Chao-Hui Huang, Andres Azuero, et al. (+4)
303 [GO] 2021―Sep―21 Hospital admissions and place of death prior and during COVID-19: Real-world data from a Brazilian cancer center. Karla Lúcia Lucia Nascimento, Errol James Philip, Luana Sacchi, Juliana Pereira, Jose Nazario, Joao Nunes Matos Neto, et al. (+3)
304 [GO] 2021―Sep―21 Recovery of a quality improvement project during the COVID pandemic. Melanie Lynn Powis, Alyssa Macedo, Monika K. Krzyzanowska, Vishal Kukreti, Lucy Xiaolu Ma, Saidah Hack, Celina Dara
305 [GO] 2021―Sep―21 Leveraging social determinants of health to reduce hospital length of stay: A pilot quality improvement project to address inpatient cancer patients' barriers during the COVID 19 pandemic. Sailaja Kamaraju, Dave Atkinson, Thomas Wetzel, Tamiah Wright, John A. Charlson, Jennifer Cadman, et al. (+2)
306 [GO] 2021―Sep―21 Improving the completion rate of outpatient stool-based colon cancer screening during a global pandemic. Ye Aung, Christian Scherer, Andrew Gdowski, Doris Cubas, Alexandra Horton, Nabeel Saghir, Holli Sadler
307 [GO] 2021―Aug―10 Caregiver Exclusion in Fighting Cancer During COVID-19: Splitting the Risk, Doubling the Team Matteo Moroni, Eduardo Bruera
308 [GO] 2021―Jun―04 Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C) Noha Sharafeldin, Benjamin Bates, Qianqian Song, Vithal Madhira, Yao Yan, Sharlene Dong, et al. (+8)
309 [GO] 2021―Jun―02 Patient-reported barriers to online meetings: The case of a myeloma support group in western Kenya in the era of COVID-19. Mercy Oduor, Kelvin Manyega, Therese Lotodo, Austin Okuku, Diana Namaemba, Lorraine Oyolo, et al. (+2)
310 [GO] 2021―Jun―02 Long-term follow-up of adult hematopoietic stem cell transplant recipients diagnosed with COVID-19. Stephanie Hoffman, Pavan Reddy, John Martin Magenau, Attaphol Pawarode, Brian Parkin, Sarah Marie Anand, et al. (+4)
311 [GO] 2021―Jun―02 Parameters of cellular immunity in patients with lymphomas after COVID-19. Inna A. Kamaeva, Irina B. Lysenko, Aleksandr B. Sagakyants, Elena S. Bondarenko, Oksana G. Shulgina, Nadezhda V. Nikolaeva, et al. (+6)
312 [GO] 2021―Jun―02 Cancer COVID Watch: A feasibility study of intensive remote symptom monitoring via automated text messages with integrated nurse practitioner triage for patients with cancer and suspected or confirmed COVID-19. Cody Cotner, Christopher Manz, Mohan Balachandran, Will Ferrell, Neda Khan, Michael Kopinsky, et al. (+7)
313 [GO] 2021―Jun―02 Implementing virtual mind-body programming to support cancer patients during COVID-19. Jun J. J. Mao, Kin Wai (Tony) Hung, Nicholas Emard, Fernanda C. G. Polubriaginof, Kathleen Lynch, Thomas Michael Atkinson, et al. (+2)
314 [GO] 2021―Jun―02 NCI’s national treatment trial networks: Experience and adaptations during COVID-19. Margaret M. Mooney, Grace E. Mishkin, Matthew J Boron, Andrea M. Denicoff, Shanda Finnigan, Marjorie J. Good, et al. (+10)
315 [GO] 2021―Jun―02 Oncology patients’ perspectives on remote patient monitoring for COVID-19. Robert Michael Daly, Tara Lauria, Jessie C. Holland, Jericho Garcia, Jibran Majeed, Chasity Walters, et al. (+5)
316 [GO] 2021―Jun―02 Association of use of remote patient monitoring (RPM) with reduced hospitalizations in cancer patients with COVID-19. Joshua Pritchett, Aakash Desai, Bijan J Borah, Zhuoer Xie, Antoine N Saliba, Konstantinos Leventakos, et al. (+8)
317 [GO] 2021―Jun―02 COVID-19 and cancer care: Embedding high-value changes into practice. Vivienne Milch, Carolyn Der Vartanian, Melissa Austen, Rhona Wang, Candice-Brooke Woods, Lillian Liu, et al. (+3)
318 [GO] 2021―Jun―02 Effect of Bacillus Calmette-Guerin (BCG) exposure on severity of COVID-19 infection: A COVID-19 and Cancer Consortium (CCC19) study. Andrew Lachlan Schmidt, Ziad Bakouny, Chris Labaki, Babar Bashir, Jessica M. Clement, Natasha Catherine Edwin, et al. (+11)
319 [GO] 2021―Jun―02 COVID-19 and cancer: How outpatients (pts) and their caregivers (CGs) face to the pandemic-A survey from the midst of the Italian outbreak. Maria Silvia Cona, Davide Dalu, Eliana Rulli, Francesca Galli, Selene Rota, Sabrina Ferrario, et al. (+9)
320 [GO] 2021―Jun―02 COVID-19 and cancer: Strategic health promotion for indigenous Australians during a pandemic. Carolyn Der Vartanian, Vivienne Milch, Gail Garvey, Cleola Anderiesz, Jane Salisbury, Candice-Brooke Woods, et al. (+3)
321 [GO] 2021―Jun―02 COVID-19 and hematologic diseases: Risk factors and long-term follow-up of CHRONOS19 Registry. Kristina Zakurdaeva, Olga A. Gavrilina, Anastasia N. Vasileva, Sergei Dubov, Vitaly S. Dubov, Lev S. Butaev, et al. (+14)
322 [GO] 2021―Jun―02 COVID-19 communication to English- and Spanish-speaking cancer patients: A website analysis of seven healthcare systems in north Texas. Robin T. Higashi, John W. Sweetenham, Aimee D. Israel, Jasmin A. Tiro
323 [GO] 2021―Jun―02 SER-ONCOVID: Seroconversion in solid-tumor cancer patients after COVID-19 diagnosis. Anna Pous, Eudald Felip, Olatz Etxaniz, Ainhoa Hernandez Gonzalez, Sofia España, Margarita Romeo, et al. (+3)
324 [GO] 2021―Jun―02 COVID-19 disease in patients with LUNG cancer in Spain: GRAVID LunG canceR pAtients coVid19 Disease (GRAVID STUDY). Mariano Provencio, Jose Maria Mazarico, Antonio Calles, Monica Antoñanzas, Cristina Pangua, Xabier Mielgo, et al. (+14)
325 [GO] 2021―Jun―02 COVID-19 effect on cancer diagnosis: A retrospective comparative analysis. Meytal Shtayer Fabrikant, Christian Miller, Christiane Morecock, Brooke Burgess, Christina Darwish, Richard Amdur, Rebecca Davidson Kaltman
326 [GO] 2021―Jun―02 An optimized mathematical model for cancer patient care planning in the COVID-19 era. Isabel Blancas, David Martínez-Rodríguez, Fernando Rodríguez-Serrano, Rafael Jacinto Villanueva, Jose Manuel Garrido
327 [GO] 2021―Jun―02 The future of tele-oncology: Trends and disparities in telehealth and secure message utilization in the COVID-19 era. Elad Neeman, Liisa Lyon, Hongxin Sun, Carol Andrea Conell, Mary Reed, Deepika Kumar, et al. (+4)
328 [GO] 2021―Jun―02 Implementation of virtual mentoring to optimize collection of patient-reported data in the COVID-19 era: A prospective cohort study with adaptive design. Karineh Kazazian, Jessica Bogach, Wendy Johnston, Carol Jane Swallow
329 [GO] 2021―Jun―02 Outcomes of COVID-19 in cancer patients: Report from the National COVID Cohort Collaborative (N3C). Noha Sharafeldin, Jing Su, Vithal Madhira, Qianqian Song, Eileen Lee, Nathaniel Kuhrt, et al. (+5)
330 [GO] 2021―Jun―02 Outcomes with COVID-19 in hematopoietic stem cell transplant and cellular therapy patients. Muhammad Umair Mushtaq, Mary Luder, Moazzam Shahzad, Nausheen Ahmed, Haitham Abdelhakim, Rajat Bansal, et al. (+10)
331 [GO] 2021―Jun―02 Patterns in cancer management changes for patients with COVID-19 in northern California. Michael Glover, Julie Wu, Daniel H Kwon, Sylvia Zhang, Solomon Henry, Douglas Wood, et al. (+6)
332 [GO] 2021―Jun―02 CORONET; COVID-19 in Oncology evaluatiON Tool: Use of machine learning to inform management of COVID-19 in patients with cancer. Rebecca Lee, Oskar Wysocki, Cong Zhou, Antonio Calles, Leonie Eastlake, Sarju Ganatra, et al. (+13)
333 [GO] 2021―Jun―02 Outcomes with COVID-19 in patients with hematopoietic stem cell transplant and cellular therapy: A systemic review and meta-analysis. Sibgha Gull Chaudhary, Muhammad Usman Zafar, Maha Awaiz Hassan, Moazzam Shahzad, Ali Hussain, Fatima Ali, et al. (+10)
334 [GO] 2021―Jun―02 Retrospective study for the characterization of COVID-19 in renal cancer (COVID-REN) patients treated with antiangiogenics or immunotherapy and outcome comparison with non-infected cases. Jesus Garcia Donas, Guillermo de Velasco, Teresa Alonso Gordoa, Jesús Chamorro, Diana Rosero, Olatz Etxaniz, et al. (+13)
335 [GO] 2021―Jun―02 Impact of COVID-19 in the screening and treatment of breast cancer in the Brazilian public health system: Data from a healthcare data warehouse. Alessandra Menezes Morelle, Fernando Castilho Venero, Rafael Dal Ponte Ferreira, Pedro Tofani Santanna, Rommel Fabricio Pereira da Silva, Patrícia Zieguelmann
336 [GO] 2021―Jun―02 Determinants of enhanced vulnerability to Covid-19 in U.K. cancer patients: Results from the OnCovid study. David James Pinato, Lorenza Scotti, Alessandra Gennari, Emeline Colomba, Ailsa Sita-Lumsden, Angela Loizidou, et al. (+14)
337 [GO] 2021―Jun―02 Acute kidney injury and major outcomes in cancer patients with no history of chronic kidney disease (CKD) with coronavirus 2019 (COVID-19) infection. Cesar Simbaqueba, Omar Mamlouk, Kodwo Dickson, Josiah Halm, Sreedhar Mandayam, Anastasia Turin, et al. (+2)
338 [GO] 2021―Jun―02 Acute thromboembolic events (TE) within 30 days of COVID-19 infection in cancer patients. Phaedon D. Zavras, Rafi Kabarriti, Vikas Mehta, Sanjay Goel, Henny Heisler Billett
339 [GO] 2021―Jun―02 Covid-19 infection in patients with a history of everolimus use. Metin Pehlivan, Adnan Aydiner
340 [GO] 2021―Jun―02 Outcomes of active cancer patients with COVID-19 infection treated with COVID-19 neutralizing monoclonal antibodies. Justin Shaya, Aaron Lee, Angelo Cabal, Rana R. McKay
341 [GO] 2021―Jun―02 Cancer patients diagnosed with COVID-19 infection: A multicenter retrospective cohort of nine Brazilian cancer centers. Tiago Costa de Padua, Mariana Ribeiro Monteiro, Kaique Almeida, Camila Brambilla Souza, Daniela Pezzutti, Maria Clara Borges De Andrade, et al. (+12)
342 [GO] 2021―Jun―02 Prognostic impact of obesity in cancer patients with COVID-19 infection: A systematic review and meta-analysis. Robin Park, Elizabeth Marie Wulff-Burchfield, Kathan Mehta, Weijing Sun, Anup Kasi
343 [GO] 2021―Jun―02 Description of asymptomatic cancer patients with COVID-19 infection: Experience of the ACHOCC-19 study in one Latin American country. Aylen Vanessa Ospina Serrano, Ricardo Elias Bruges Maya, William Armando Mantilla, Ivan Camilo Triana, Pedro Ramos, Sandra Aruachan, et al. (+14)
344 [GO] 2021―Jun―02 Machine learning prediction of COVID-19 mortality in cancer patients. Rodrigo Dienstmann, Marcia Menezes, Matheus Costa e Silva, Heloisa Cruz, Rafael Paes, Jussaine Alves da Silva, et al. (+11)
345 [GO] 2021―Jun―02 The HOLA COVID-19 study: Evaluating the impact of caring for patients with COVID-19 on cancer care delivery in Latin America. Carolina Bernabe Ramirez, Ana I. Velazquez Manana, Coral Olazagasti, Cristiane Decat Bergerot, Enrique Soto Perez De Celis, Jose Francisco Corona-Cruz, et al. (+14)
346 [GO] 2021―Jun―02 The impact of COVID-19 on clinical cancer care: An individual-patient level analysis. Lynsey M Drewett, Sian Alexandra Pugh, Rosalind Kieran, Binu Nair, Hossameldin Attia, Muhammad Iftikhar Sabar, et al. (+14)
347 [GO] 2021―Jun―02 Impact of COVID-19 on delay in cancer diagnostic testing. Anna Juncker-Jensen, Corine K. Lau, Manan Shah, Lawrence Martin Weiss, Eve Shinbrot
348 [GO] 2021―Jun―02 The impact of COVID-19 on delivery of systemic anti-cancer treatment in urological cancer patients: A comparison with 2019 data from Guy’s Cancer Center. Christina Karampera, Muhammad Khan, Beth Russell, Charlotte Moss, Maria J Monroy-Iglesias, Saoirse Dolly, et al. (+6)
349 [GO] 2021―Jun―02 Impact of COVID-19 on initial treatment of breast and colorectal cancers in one integrated healthcare system. Jayasree P. Sundaram, Su-Ying Liang, Natalia Colocci, Monique A. De Bruin
350 [GO] 2021―Jun―02 The impact of COVID-19 on oncologists: Experience from Egyptian physicians. Abeid Mohamed Athman Omar, Marwa Ramadan, Yomna Khamis, Abdelsalam A. Ismail
351 [GO] 2021―Jun―02 The impact of COVID-19 on patients with cancer: A qualitative study. Dhanya Kumar, Sana Khateeb, Manali I. Patel
352 [GO] 2021―Jun―02 Trends in new cancer treatments with targeted molecular therapies before and during the COVID-19 outbreak in Veneto, Italy: A real-world, population-based study. Fabio Girardi, Sandro Tognazzo, Alberto Bortolami, Marina Coppola, Valentina Guarneri, Pier Franco Conte
353 [GO] 2021―Jun―02 Patient navigation plus hospital at home to improve COVID-19 outcomes for cancer patients. Brittany K. Ragon, Ashley Love Sumrall, Kris Blackley, Ify Osunkwo, Tamara Kay Moyo, Laura Kabrich, et al. (+12)
354 [GO] 2021―Jun―02 COVID-19 outcomes in patients with a history of breast cancer: A diverse multicenter Los Angeles cohort study. Nikhita Kathuria-Prakash, Lauren Antrim, Alexander W Sun, Irene Kang, Maria De Lourdes Garcia-Jimenez, Trevor E Angell, et al. (+2)
355 [GO] 2021―Jun―02 Ensuring equity in the management of patients, over 70 years of age, on immunotherapy during the COVID-19 pandemic. Frederik Jorde, Hannah Taylor, Lucy Lipinski, Christopher Herbert, Jessica Ball, Helen Winter
356 [GO] 2021―Jun―02 Revamping the delivery of cancer support, education, and wellness programming during the COVID-19 pandemic. Lisa Capparella, Ana Maria Lopez, Kristine Naputo, C. Virginia Virginia O'Hayer, Gregory D. Garber, Amy Leader, Miriam Pomerantz
357 [GO] 2021―Jun―02 Assessment of National Comprehensive Cancer Network (NCCN) guideline adherence for lung cancer in a community teaching hospital during COVID-19 pandemic. Mahati Paravathaneni, Vihitha Thota, Bohdan Baralo, Sana Mulla, Eugene Jinkyu Choi, Rajesh Thirumaran
358 [GO] 2021―Jun―02 Patient concerns and disruptions in cancer care during the COVID-19 pandemic. Erica E. Fortune, Jemeille Ackourey, Thomas William LeBlanc, Heather Badt, Alexandra Katherine Zaleta
359 [GO] 2021―Jun―02 Evolving oncology provider perspectives on care delivery during the COVID-19 pandemic. Divya Ahuja Parikh, Meera Vimala Ragavan, Sandy Srinivas, Sarah Garrigues, Eben Lloyd Rosenthal, Manali I. Patel
360 [GO] 2021―Jun―02 Changes in prescribing of oral capecitabine versus intravenous (IV) 5-fluorouracil (5-FU) in gastrointestinal (GI) cancers during the COVID-19 pandemic. Yasin Civelek, Daniel Cullen, David Joseph Debono, Michael Jordan Fisch, John Barron, Gosia Sylwestrzak
361 [GO] 2021―Jun―02 Patient care and clinical trials in gynecological oncology: Implications of the COVID-19 pandemic. Sara Nasser, Christina Fotopoulou, Murat Guktekin, Desislava Dimitrova, Philippe Morice, Jalid Sehouli
362 [GO] 2021―Jun―02 Distress screening for patients with a history of cancer during the COVID-19 pandemic. Brooke Worster, Lauren Waldman, Gregory D. Garber, Subecha Dahal, Adam F Binder, Valerie Pracilio Csik, et al. (+5)
363 [GO] 2021―Jun―02 Joven y Fuerte (J&F): Multidisciplinary distance care program in Mexico for young women with breast cancer (YWBC) during the COVID-19 pandemic. Lucero Labra, Andrea Guerra-Anlen, C. Lizette Galvez, Juan Torres, Alan Fonseca, Cynthia Villarreal-Garza, et al. (+9)
364 [GO] 2021―Jun―02 The inhibitory effect of cisplatin, paclitaxel, and pemetrexed on the growth of PC9GR cells resistant to NK cell-mediated cytotoxicity during the COVID-19 pandemic. Md Mohiuddin, Hideharu Kimura, Satoshi Watanabe, Miki Abo, Takashi Sone, Keigo Saeki, et al. (+3)
365 [GO] 2021―Jun―02 Results of a German survey among patients with gynecological malignancies during the COVID-19 pandemic. Desislava Dimitrova, Robert Armbrust, Sara Nasser, Seyma Boz, Dario Zocholl, Emelina Fucaraccio, et al. (+2)
366 [GO] 2021―Jun―02 The mechanism of the growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic. Md Mohiuddin, Hideharu Kimura, Satoshi Watanabe, Miki Abo, Takashi Sone, Keigo Saeki, et al. (+3)
367 [GO] 2021―Jun―02 Oncology trial enrollment trends following the first wave of the COVID-19 pandemic. Elizabeth W. Lamont, Kevin Blum, Ron G. Katriel, Lisa G Ensign
368 [GO] 2021―Jun―02 The impact of converting to telehealth for cancer genetic counseling and testing during the COVID-19 pandemic. Katherine Crawford, Ekaterina Koelliker, Ellie Proussaloglou, Jessica Laprise, Jennifer Scalia Wilbur, Katina Robison, Ashley Stuckey
369 [GO] 2021―Jun―02 Building capacity and ensuring equity in clinical trials during the COVID-19 pandemic. Helen Winter, Joanna Willis, Stephen Lang, Kay Drury, Jonathan Heywood, Jeremy Bewley, et al. (+5)
370 [GO] 2021―Jun―02 Psychosocial impact of COVID-19 pandemic among patients under oncological treatment. Daniela Pezzutti Domingues Armentano, Mariana Sarkis Braz, Veronica Montanher, Danielle Lopes Palermo, Renata Carolina Giuliano, Janaina Lopes Eleuterio Silva, et al. (+12)
371 [GO] 2021―Jun―02 Results from a global survey of clinical cancer researchers on clinical trial design and conduct during the COVID-19 pandemic and beyond. Bruno Henrique Rala De Paula, Gary Doherty
372 [GO] 2021―Jun―02 Patterns of telehealth utilization during the COVID-19 pandemic and preferences for post-pandemic telehealth use: A national survey of oncology clinicians. Christopher Manz, Nancy N. Baxter, Nefertiti C. duPont, Merry Jennifer Markham, Caitlin Drumheller, Lela Durakovic, Angela Kennedy
373 [GO] 2021―Jun―02 Side effects of extended interval dosing of checkpoint inhibitors among patients during COVID-19 pandemic at the Moncton and the Miramichi hospitals. Mahmoud Abdelsalam, Rana Sughayar, Glenn Myers, Mrudula Avileli, Maged Salem
374 [GO] 2021―Jun―02 Improving the inclusion rate in clinical trials of bladder cancer despite COVID-19 pandemic by using ASCO quality training program. Natalia Vidal, Juan Gomez, Isabel Galante, Jose Luis Senovilla, Jose-Luis Gonzalez-Larriba, Carmen Toledano, et al. (+7)
375 [GO] 2021―Jun―02 Reduction in prostate cancer hospitalizations in the COVID-19 pandemic epicenter of Latin America. Isabella Batista Martins Portugal, Fernando Adami, Jean Henri Schoueri, Leandro Fórnias Machado Rezende, Fernando Luiz Affonso Fonseca, Gerson Ferrari, et al. (+2)
376 [GO] 2021―Jun―02 Team huddle, education and infection screening as effective tools in continuing cancer care delivery during the peak of COVID-19 pandemic in 2020 in the Bronx, NY: Experience from a public teaching hospital. Surabhi Pathak, Roshni Narurkar, Mohammed Hasan Khan, Bei Jiang, May Nyein Chann Soe, Monica Muppidi, Caroline Hwang
377 [GO] 2021―Jun―02 Treatment changes in prostate cancer patients on active treatment during the COVID-19 pandemic in a community cancer center in New York City. Rose Snyder, Trishala Meghal, Andrew Wood, Ariel Schulman, Kevin Douglas Becker, Yiwu Huang, et al. (+3)
378 [GO] 2021―Jun―02 Perceptions of cancer patients and their caregivers regarding COVID-19 pandemic in Ethiopia. Aynalem Abraha Woldemariam, Nataliya Berbyuk Lindström, Rune Andersson, Adamu Addissie
379 [GO] 2021―Jun―02 Impact of COVID-19 pandemic in hospitalizations due to brain tumors from the epicenter of Latin America. Isabella Batista Martins Portugal, Luis Eduardo Werneck De Carvalho, Jean Henri Schoueri, Leandro Fórnias Machado Rezende, Fernando Luiz Affonso Fonseca, Gerson Ferrari, et al. (+2)
380 [GO] 2021―Jun―02 Impact of the COVID-19 pandemic in treating gastrointestinal (GI) cancer patients receiving systemic anticancer treatment (SACT): The Guy's Cancer Centre experience. Jose Roca, Ailsa Sita-Lumsden, Eirini Tsotra, Charalampos Gousis, Beth Russell, Charlotte Moss, et al. (+14)
381 [GO] 2021―Jun―02 The COVID-19 pandemic led to a reduction in cancer services in Australia. Christine Biondi, Vivienne Milch, Van Nguyen, Regina Ryan, David Roder, Alan Woods, et al. (+4)
382 [GO] 2021―Jun―02 The impact of COVID-19 pandemic on access to new patient cancer care as evaluated in the Integra Connect Database (ICD). Mike Gart, Prateesh Varughese, Lucio N. Gordan, Trevor Heritage, Greg Brown, Elizabeth Botts, et al. (+4)
383 [GO] 2021―Jun―02 Impact of the COVID-19 pandemic on care delivery and outcomes for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). Ravi Kumar Paluri, Paul Cockrum, Ashley Ann Laursen, Joseph Louis Gaeta, Shu Wang, Andy Surinach
384 [GO] 2021―Jun―02 Impact of the COVID-19 pandemic on clinical activity during the lockdown in North France: A single center experience. Ali Hammoudi, Guillaume Marliot, Margot Cucchi, Naima Mahi, Diane Pannier, Eric Leblanc, et al. (+5)
385 [GO] 2021―Jun―02 Impact of the COVID-19 pandemic on health care activities at a Uruguayan mastology teaching unit: Preliminary results. Cecilia Castillo, Natalia Camejo, Dahiana Amarillo, Florencia Rodriguez, Florencia Vitureira, Gabriel David Krygier, Lucia Beatriz Delgado
386 [GO] 2021―Jun―02 The impact of the COVID-19 pandemic on oncology clinical trial recruitment in an Irish cancer center. Ronan Andrew McLaughlin, Valerie Madigan, Maureen O'Grady, Thamir Andrew Mahgoub, Roshni Andrew Kalachand, Nemer Osman, et al. (+2)
387 [GO] 2021―Jun―02 The impact of COVID-19 pandemic on oncology workload: The experience of an Italian Reference Cancer Center. Carla Corvaja, Giada Targato, Silvio Ken Garattini, Cristina Barazzutti, Alessandra Bin, Raffaela Donato, et al. (+5)
388 [GO] 2021―Jun―02 Impact of the COVID-19 pandemic on staging at presentation of patients with invasive melanoma. Saba Shaikh, Xi Yang, Dylan Fortman, Hong Wang, Diwakar Davar, Jason J. Luke, et al. (+3)
389 [GO] 2021―Jun―02 Impact of COVID-19 pandemic on time to treatment initiation for patients with advanced cancer. Samuel U Takvorian, Ravi Bharat Parikh, Daniel Vader, E. Paul Wileyto, Amy Sanders Clark, Daniel J. Lee, et al. (+14)
390 [GO] 2021―Jun―02 Impact of the COVID-19 pandemic on treatment in patients (pts) with gynecological (GYN) cancer: A comparison with 2019 data from Guy’s Cancer Centre. Vasiliki Michalarea, Styliani Germanou, Andreja Podvez Nevajda, Ketevan Eremeishvili, Rushan Sylva, Kalliopi Michoglou, et al. (+14)
391 [GO] 2021―Jun―02 The national impact of the COVID-19 pandemic on U.S. prostate cancer community care. Matthew R. Cooperberg, Paul Brendel, Daniel J. Lee, Rahul Doraiswami, Hariesh Rajasekar, Danil V. Makarov, et al. (+4)
392 [GO] 2021―Jun―02 Distress in a pandemic: The association of the coronavirus disease-2019 (COVID-19) pandemic with distress and quality of life in hematopoietic stem cell transplantation (HSCT). Hermioni L. Amonoo, Carlisle E. W. Topping, Madison A. Clay, Thomas William LeBlanc, Joseph A. Greer, Stephanie Lee, et al. (+2)
393 [GO] 2021―Jun―02 Association of the COVID-19 pandemic with patterns of cancer services. Robin Robin Yabroff, Xiao-Cheng Wu, Serban Negoita, Jennifer Stevens, Linda Coyle, Jingxuan Zhao, et al. (+3)
394 [GO] 2021―Jun―02 Evaluation of patient navigation and delivery of head and neck cancer therapy during COVID-19 pandemic: A single institution experience. Sherri Rauenzahn Cervantez, Ruben A. Mesa, Jeremy Viles, Mary Salazar, Leslie Villarreal, Mark Bonnen, Joshua Asper
395 [GO] 2021―Jun―02 Telemedicine use and satisfaction amongst radiation oncologists during the COVID-19 pandemic: Evaluation of current trends and future opportunities. Alok Deshane, Nicholas Damico, Michael Kharouta, Anna Wu, GI-Ming WANG, Mitchell Machtay, et al. (+3)
396 [GO] 2021―Jun―02 Decrease of oncological patients’ hospital visits during Covid-19 pandemic: The experience of a tertiary Romanian center. Cristina Crisan, Calin Ioan Cainap, Andrada Larisa Deac, Andrei Dan Havasi, Ovidiu Balacescu, Loredana Balacescu, et al. (+3)
397 [GO] 2021―Jun―02 Association of systemic anticancer therapy with an increased risk of death in hospitalized COVID-19 positive oncology patients. David Jacob Hermel, Samantha R. Spierling Bagsic, Munveer Singh Bhangoo, Kathryn Blount Bollin, James R. Mason, Alan Saven, Darren Sigal
398 [GO] 2021―Jun―02 Incidence of asymptomatic COVID-19 positivity in cancer patients and effects on therapy. Nicole Ross, Elizabeth A. Handorf, Caitlin R. Meeker, Giana Chen, Donald Baldwin, Namrata Vijayvergia
399 [GO] 2021―Jun―02 COVID-19 related outcomes for hospitalized patients (pts) with solid malignancies (SM). Jeffrey Chi, David Chitty, Nina Kohn, Janice Shen, Carlos Alberto Lopez, Adam Hines, et al. (+4)
400 [GO] 2021―Jun―02 Global trends of COVID-19 research in cancer: A scientometric study. Noha Sharafeldin, Hai Quang Pham, Long Hoang Nguyen, Giang Thu Vu, Trang Huyen, Tham Thi Nguyen, Bach Xuan Tran
401 [GO] 2021―Jun―02 A nurse-led telephone triage for the prevention and control of COVID-19 spread in an oncology department. Lorenzo Calvetti, Francesca Simionato, Alessandro Cappetta, Francesca La Russa, Roberta Cimenton, Barbara Gasparin, et al. (+2)
402 [GO] 2021―Jun―02 Hematologic malignancy patients suffer higher mortality and morbidity from COVID-19 than solid tumor patients. Maxwell Masters Krem, Snigdha Nutalapati, Hannah L. Latta, Chris Z. Thomas, Hanine El Haddad, Gabriel A. Vilchez, Gerhard Hildebrandt
403 [GO] 2021―Jun―02 Psychosocial impacts of COVID-19 upon a diverse Australian oncology workforce: From doctors to ancillary staff. Elizabeth Stephanie Ahern, Natasha Anne Roberts, Bryan Anthony Chan, Harry Michael Gasper, Anita Pelecanos, Glen Kennedy, et al. (+2)
404 [GO] 2021―Jun―02 Adverse effects of COVID-19 vaccination among cancer patients: Results from an Internet-based survey. Brian Loew, Richard Tsai, John Hervey, Kathleen D. Hoffman, John Novack, Jennifer Johnson, et al. (+2)
405 [GO] 2021―Jun―02 People with cancer are likely to accept the COVID-19 vaccine, but politics tracks with attitudes: An inspire and COSMO survey. Don S. Dizon, Kathleen D. Hoffman, Danielle Gentile, Richard Tsai, John Novack, Deanna J. Attai, et al. (+5)
406 [GO] 2021―Jun―02 Landscape of COVID-19 vaccine uptake in the colorectal cancer community: Responding to community needs. Andrea Dwyer, Michael Marosits, Elsa Weltzien, Reese Garcia, Anjee Davis
407 [GO] 2021―Jun―02 Phase 2 analysis on Covid-19-adopted etoposide (E) and cisplatin (P) regimens for patients (pts) with an advanced germ cell tumor (GCT): The CovGCT study. Nabeel Naban, Gesa Tiemeier, Arwa Kocache, Rory Taylor, Georgina Keogh, Lindsay Hennah, et al. (+3)
408 [GO] 2021―Jun―02 Cancer care in the time of COVID-19: A conceptual framework to improve cancer outcomes during a pandemic. Vivienne Milch, Cleola Anderiesz, Debra Hector, Scott Turnbull, Melissa Austen, Rhona Wang, et al. (+2)
409 [GO] 2021―Jun―02 Cancer Care during Covid-19: A multi-institutional qualitative study on physician and patient perspectives on telemedicine. Bonnie O. Wong, Rebecca Aslakson, Laura M Holdsworth, Rachel Siden, Holly Tabor, Mae-Richelle Verano, Lidia Schapira
410 [GO] 2021―Jun―02 Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: A propensity score-based analysis. Mateus Bringel Oliveira Duarte, Frederico Leal, Juliana Luz Passos Argenton, Jose Barreto Campello Carvalheira
411 [GO] 2021―Jun―02 Cancer and COVID-19: A proposed mechanism with therapeutic interventions. Yan Leyfman, Nancy Emmanuel, Aleksey Tentler, Jared Cappelli, Timothy K Erick, Pushpa Sharma, Chandler H. Park
412 [GO] 2021―Jun―02 Association and prevalence of venous thromboembolism in cancer patients with COVID-19: A single healthcare system experience. Aneesha Ananthula, Dat Tran, Katharine Thomas, Katie Lauren McLemore McQueen Amaker, Anh Nguyen, Soham Mahato, et al. (+3)
413 [GO] 2021―Jun―02 Clinical outcomes of cancer patients with COVID-19: A systematic review and meta-analysis. Maryam Alasfour, Salman Alawadi, Malak AlMojel, Philippos Apolinario Costa, Priscila Barreto Coelho, Thomas Plate, et al. (+2)
414 [GO] 2021―Jun―02 Cancer care during COVID-19: Data from 157 patient organizations. Lorna Warwick, Elisabeth Baugh, Fatima Cardoso, Rachel H. Giles, Alex Filicevas, Jesme Fox, et al. (+7)
415 [GO] 2021―Jun―02 Your voice matters during COVID-19: Evaluation of digital divides across a tertiary cancer center. Amir Safavi, Mike Lovas, Zhihui (Amy) Liu, Sheena Melwani, Tran Truong, Shayla Devonish, et al. (+3)
416 [GO] 2021―Jun―02 Clinical characteristics and outcomes of cancer patients with chronic kidney disease and coronavirus disease 2019. Omar Mamlouk, Anastasia Turin, David D'Achiardi, Cesar Simbaqueba, Kodwo Dickson, Maria Franco-Vega, et al. (+2)
417 [GO] 2021―Jun―02 Very low seroprevalence of sars-cov-2 among health care personnel (HCP) in a French northern comprehensive cancer center at the end of first national containment. Philippe Doutrelant, Nicolas Penel, Charlotte Renaudat, Cassandre Von Platen, Marie Paule Lebitasy, Pauline Smis-Papillon, et al. (+3)
418 [GO] 2021―Jun―02 Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients (p): SOLID study. Mariano Provencio, Delvys Rodriguez-Abreu, Ana Collazo Lorduy, Gloria Mª Serrano, Ana Laura Ortega Granados, Carlos Aguado, et al. (+13)
419 [GO] 2021―Jun―02 Risk factors for hospitalization for cancer patients with SARS-CoV-2 infection. Zainab Shahid, Emily Baldrige, Sally Trufan, Courtney Schepel, Antoinette R. Tan, Jimmy J. Hwang, et al. (+11)
420 [GO] 2021―Jun―02 Matched case control analysis of breast cancer specific factors impacting risk of developing SARS-Cov-2 infection. Joanna Zurko, Aniko Szabo, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind, Janet Retseck, et al. (+2)
421 [GO] 2021―Jun―02 Social distancing to avoid SARS-Cov-2 infection in cancer and non-cancer patients. Goetz H. Kloecker, Jason Ellis, Leslie Korbee, Joseph Nolan, Royce Calhoun, Barbara Logan, et al. (+3)
422 [GO] 2021―Jun―02 Risk for SARS-CoV-2 infection in patients with breast cancer treated with chemotherapy, biologic therapy or active surveillance: Patient outcomes from multicenter institution in New York. Nibash Budhathoki, John Kucharczyk, Nina D'Abreo, Maryann J. Kwa, Magdalena Plasilova, Shubhada Dhage, et al. (+14)
423 [GO] 2021―Jun―02 Mortality in adult patients with solid or hematological cancers and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: A systematic review and meta-analysis. Marco Tagliamento, Elisa Agostinetto, Marco Bruzzone, Marcello Ceppi, Kamal S. Saini, Evandro de Azambuja, et al. (+7)
424 [GO] 2021―Jun―02 INTENSIVE: InterNaTional rEgistry oN Sars-cov-2 posItiVe nEuroendocrine neoplasm patients. Francesca Spada, Lorenzo Gervaso, Anna La Salvia, Rocio Garcia-Carbonero, Jorge Hernando, Jaume Capdevila, et al. (+12)
425 [GO] 2021―Jun―02 Upper respiratory tract SARS-CoV-2 viral shedding in cancer patients. Zainab Shahid, Emily Baldrige, Sally Trufan, Courtney Schepel, Antoinette R. Tan, Jimmy J. Hwang, et al. (+11)
426 [GO] 2021―Jun―02 Does prior treatment with anti-PD 1 immune check point inhibitors (ICIs) mitigate infection with herpes and SARS-CoV-2 viruses: Clinical evidence supporting basic hypotheses. Apoorva Jayarangaiah, Richard J. Gralla, Beth McLellan
427 [GO] 2021―Jun―02 SARS-CoV2 infection rate in patients and health care personnel in a chemoradiotherapy unit: A prospective cohort in Mexico. Mónica Isabel Meneses Medina, Jorge Humberto Hernandez-Felix, Vanessa Rosas Rosas Camargo, Ana Karen Valenzuela, Alberto Cedro-Tanda, Edgar Omar Martos Armendariz, et al. (+6)
428 [GO] 2021―Jun―02 Modified operations to permit safe and timely delivery of essential surgical care for high-risk skin cancer during a pandemic. Stephanie Renae Jackson Cullison, Arda Celen, Nicole Adell Doudican, Mary Stevenson, John A. Carucci
429 [GO] 2021―Jun―02 Measuring the impact and sustainability of a statewide program for identifying minority and underserved clients at risk for hereditary breast and ovarian cancer (HBOC): An eight-year follow up including transitions during the COVID pandemic. Alice S. Kerber, Sheryl G. A. Gabram, Diane Durrence, Janet Y. Shin, Nancy M. Paris, Lynn M. Durham
430 [GO] 2021―Jun―02 Cancer care system strengthening (Pendharkar model) offers uninterrupted care continuum during COVID19 pandemic. Dinesh Pendharkar, Chandramauli Tripathi
431 [GO] 2021―Jun―02 Can COV Direct: Effectiveness of a tele-medicine self- care interventions for cancer survivors during COVID 19 pandemic. Narayanankutty Edavalath Warrier, Uma V Sankar, Sreedharan P. S., Prasanth V. Parameswaran, Sajeevan K. V., Nirmal V
432 [GO] 2021―Jun―02 Comparing implementation of Telemedicine compliance and feasibility among oncology patients across countries during the COVID 19 pandemic. Sharon Pelles, Shira Peleg Hasson, Barliz Waissengrin, Lior Hasid, Irad Deutsch, Tamar Safra, et al. (+2)
433 [GO] 2021―Jun―02 Patient-reported outcomes in cancer patients admitted during the COVID 19 pandemic in a tertiary Spanish hospital. Veronica Velasco Durantez, Adán Rodríguez González, Maria Pilar Solis-Hernandez, Clara Iglesias Gomez, Alfonso Revuelta, Paula Jiménez-Fonseca, et al. (+10)
434 [GO] 2021―Jun―02 Feasibility and patient perception of a web-based exercise program during COVID pandemic in breast and ovarian cancer patients. Marcos Iglesias Campos, Bella Pajares, Cristina Roldán Jiménez, Begona Jimenez, Emilio Alba, Antonio Cuesta Vargas
435 [GO] 2021―Jun―02 Impact of COVID 19 pandemic on psychological wellbeing of oncology clinicians in MENA (Middle East and North Africa) region. Muhammad Farooq Latif, Faisal Azam, Syed Hammad Tirmazy, Shahid Bashir, Fahad Ibnshamsah, Waleed Mohammed Al Selwi, et al. (+13)
436 [GO] 2021―Jun―02 Impact of COVID19 pandemic on the hospitalization burden of cancer patients: Results of a quasi-experimental study. Juan Cristobal Sanchez, Beatriz Nuñez García, Alberto Ruano, Mariola Blanco, Blanca Cantos Sanchez de Ibarguren, Miriam Mendez, et al. (+4)
437 [GO] 2021―Jun―02 Racial and ethnic disparities among patients with breast cancer and COVID-19. Gayathri Nagaraj, Melissa Kate Accordino, Benjamin French, Nicole M. Kuderer, Gary H. Lyman, Daniel G. Stover, et al. (+13)
438 [GO] 2021―Jun―02 ‘I’m being forced to make decisions I have never had to make before’: Oncologists and the conundrums created by COVID-19. Chithra R. Perumalswami, Emily Chen, Carly Martin, Susan Dorr Goold, Raymond G. De Vries, Jennifer J. Griggs, Reshma Jagsi
439 [GO] 2021―Jun―02 Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis. Elizabeth Trice Loggers, Elizabeth Marie Wulff-Burchfield, Ishwaria Mohan Subbiah, Ali Raza Khaki, Pamela Egan, Dimitrios Farmakiotis, et al. (+14)
440 [GO] 2021―Jun―02 Lower respiratory tract disease (LRTD) in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study. Dimpy P Shah, Pankil Shah, Andrew Lachlan Schmidt, Ziad Bakouny, Dimitrios Farmakiotis, Maheen Abidi, et al. (+13)
441 [GO] 2021―Jun―02 Concomitant infections in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study. Kyle T. Enriquez, Gowri Satyanarayana, Maheen Abidi, Shailesh M Advani, Pamela Egan, Arielle Elkrief, et al. (+14)
442 [GO] 2021―Jun―02 COVID-19 and exacerbation of screening mammography inequities. Gary X. Wang, Jarvis Chen, Leslie Lamb, Christian Testa, Pamela Waterman, Constance Dobbins Lehman, Nancy Krieger
443 [GO] 2021―Jun―02 COVID-19 and medical education: Rethinking student assessment-The Virtual Observational Standard Clinical Examination. Mariana Abal, Lourdes Gil Deza, Ernesto Gil Deza, Marta Dragosky, Claudia Lorena Acuna, Alba Marin Ordoñez, et al. (+12)
444 [GO] 2021―Jun―02 Outcomes for cancer patients on systemic anti-cancer therapies during the COVID-19 pandemic from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study. Valerie Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, Neha Chopra, Ekin Bamac, Meera Desai, et al. (+11)
445 [GO] 2021―Jun―02 Lessons from COVID-19, challenges of remote learning for childhood cancer survivors. Kathy Ruble, Lisa Carey, Juliana Pare-Blagoev, Kimberly Milla, Sydney Henegan, Katrina Cork, et al. (+2)
446 [GO] 2021―Jun―02 Assessment of vitamin D deficiency and COVID-19 diagnosis in patients with breast or prostate cancer using electronic medical records. Aaron Galaznik, Emelly Rusli, Vicki Wing, Rahul Jain, Sheila Diamond, David Fajgenbaum
447 [GO] 2021―Jun―02 Outcomes for hospitalized cancer patients with COVID-19 during the height of pandemic in New York City. Amelia Sawyers, Margaret Chou, Paul Johannet, Nicholas Gulati, Yingzhi Qian, Hua Zhong, Iman Osman
448 [GO] 2021―Jun―02 Initial report on hospitalized cancer patients with COVID-19 from the National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS). Nicholas M. Mark, Ana F. Best, Alok A. Khorana, Steven Pergam, Grace E. Mishkin, Melissa Bowman, et al. (+6)
449 [GO] 2021―Jun―02 Initial reporting from the prospective National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS). Larissa A. Korde, Ana F. Best, Sacha Gnjatic, Andrea M. Denicoff, Grace E. Mishkin, Melissa Bowman, et al. (+13)
450 [GO] 2021―Jun―02 Development and validation of a novel patient-reported outcomes (PRO) measure for symptom burden in patients with cancer and COVID-19 infection. Loretta A. Williams, Meagan Whisenant, Tito R. Mendoza, Donna Malveaux, Donna Griffin, Darcy Ponce, et al. (+12)
451 [GO] 2021―Jun―02 A multicenter analysis of the outcome of cancer patients with neutropenia and COVID-19 infection optionally treated with granulocyte colony-stimulating factor (G-CSF). Ana M. Jimenez Gordo, Gonzalo Colmenarejo, Javier Baena Espinar, Carlos Aguado, Xabier Mielgo, Ana Pertejo, et al. (+14)
452 [GO] 2021―Jun―02 Prognostic value of pre-infection routine laboratory parameters for COVID-19 mortality in tumor patients: Results of the ADHOK Coronavirus Tumor Registry. Romina Roesch, Thomas Suedhoff, Clemens M. Wendtner, Frank Kullmann, Thomas Kubin, Markus Schaich, et al. (+9)
453 [GO] 2021―Jun―02 The impact of COVID-19 on breast cancer stage at diagnosis. Maxwell Roger Lloyd, Sarah Jo Stephens, Julian C. Hong, Ted A. James, Tejas Mehta, Abram Recht, Daphna Spiegel
454 [GO] 2021―Jun―02 Impact of COVID-19 on work-related fatigue and satisfaction among oncology providers in Latin America: An analysis of the HOLA COVID-19 study. Ana I. Velazquez Manana, Carolina Bernabe Ramirez, Coral Olazagasti, Paulo Gustavo Bergerot, Enrique Soto Perez De Celis, Jose Francisco Corona-Cruz, et al. (+14)
455 [GO] 2021―Jun―02 Trends in cancer screening volumes at an urban health center during the COVID-19 pandemic. Mahir Khan, Margaret Wright, Karriem Watson, Shikha Jain
456 [GO] 2021―Jun―02 Reductions in cancer screening: The consequence of changes in routine care during the COVID-19 pandemic. Ashley Kim, Matthew Gitlin, Ela Fadli, November McGarvey, Ze Cong, Karen Chung
457 [GO] 2021―Jun―02 Acute and chronic cancer-related distress among multiple myeloma patients during the COVID-19 pandemic. Jenny Ahlstrom, Thomas H. Molina, Nathan W. Sweeney
458 [GO] 2021―Jun―02 Disparity in telehealth and emergency department use among Medicaid and commercially insured patients receiving systemic therapy for cancer in Washington State following the COVID-19 Pandemic. Scott David Ramsey, Laura Elizabeth Panattoni, Li Li, Qin Sun, Catherine R. Fedorenko, Hayley Sanchez, et al. (+2)
459 [GO] 2021―Jun―02 Significant decline in cancer diagnostic testing in U.S. CMS population during the COVID-19 pandemic. Dave Smart, Peter Riccelli, Keith Kerr, Jordan Clark, Susanne Munksted Fosvig, Mark Lawler
460 [GO] 2021―Jun―02 Evolution of post-traumatic stress disorder and patient reported-outcomes during the COVID-19 pandemic among cancer patients of the French longitudinal COVIPACT study. Florence Joly, Sophie Lefèvre-Arbogast, Olivier Rigal, Etienne Bastien, Lydia Guittet, Jean-Michel Grellard, et al. (+12)
461 [GO] 2021―Jun―02 Concerns and difficulties associated with the COVID-19 pandemic among older adults with cancer in Mexico. Sofia Sánchez-Román, Yanin Chavarri Guerra, Andrea Morales Morales Alfaro, Daniela Ramirez Maza, Andrea de la O Murillo, Enrique Soto Perez De Celis
462 [GO] 2021―Jun―02 The association between the coronavirus disease 2019 (COVID-19) pandemic and quality of life and depression symptoms in patients with advanced lung cancer. Lauren Heuer, Kathryn Elizabeth Post, Emily R. Gallagher, Chardria Trotter, Madeleine Elyze, Charu Vyas, et al. (+4)
463 [GO] 2021―Jun―02 Impact of COVID-19 pandemic in 2020 on the diagnosis and management of breast cancer in Korea: A multi-institutional study. Young-Joon Kang, Se Jeong Oh, Jong Min Baek, Yong-seok Kim, Ye Won Jeon, Tae-Kyung Yoo, et al. (+4)
464 [GO] 2021―Jun―02 A pilot study to prevent burnout in junior oncology doctors during the COVID-19 pandemic in a tertiary U.K. center. Alfred Chung Pui So, Sarah Hunter, Karen Chan, Anne Sagar Rigg, Sue Smith, Raselle Miller, Kiruthikah Thillai
465 [GO] 2021―Jun―02 Prostate cancer treatment disparities during the COVID-19 pandemic, lessons from a multi-institutional collaborative. Adrien Bernstein, Ruchika Talwar, Elizabeth A. Handorf, Kaynaat Syed, Serge Ginzburg, Laurence H Belkoff, et al. (+8)
466 [GO] 2021―Jun―02 The impact of the COVID-19 pandemic on African American cancer survivors living in metropolitan Detroit. Jennifer Lynn Beebe-Dimmer, Chrissy Lusk, Julie J. Ruterbusch, Tara Baird, Stephanie Pandolfi, Theresa A. Hastert, et al. (+3)
467 [GO] 2021―Jun―02 Impact of disruptions in breast cancer control due to the COVID-19 pandemic on breast cancer mortality in the United States: Estimates from collaborative simulation modeling. Oguzhan Alagoz, Kathryn P. Lowry, Allison W. Kurian, Jeanne S. Mandelblatt, Mehmet Ali Ergun, Hui Huang, et al. (+9)
468 [GO] 2021―Jun―02 Adverse consequences of the COVID-19 pandemic on breast cancer stage distribution and breast cancer disparities. Genevieve A. Fasano, Yalei Chen, Solange Bayard, Melissa Davis, Vivian Bea, Michele B. Drotman, et al. (+7)
469 [GO] 2021―Jun―02 The impact of the COVID-19 pandemic on stage at diagnosis of breast and colorectal cancers. Jade Zhou, Shelly Kane, Celia Ramsey, Melody Ann Akhondzadeh, Ananya Banerjee, Rebecca Arielle Shatsky, Kathryn A. Gold
470 [GO] 2021―Jun―02 Impact of the COVID-19 pandemic on the wellbeing of international fellows training in hematology/oncology at the Princess Margaret Cancer Centre (PMCC). Carlos Stecca, Di Maria Jiang, Marie Alt, Mary Elliott, Nazanin Fallah-Rad, Glaucia Michelis, Srikala S. Sridhar
471 [GO] 2021―Jun―02 Impact of COVID-19 pandemic on well-being and work-related burnout among healthcare workers at an academic center. Richa Dawar, Estelamari Rodriguez, Kunal Gawri, Deukwoo Kwon, Frank J. Penedo
472 [GO] 2021―Jun―02 Psychosocial impacts of the COVID-19 pandemic on young adult cancer survivors and parents of children with cancer. Stephanie M Smith, Dhanya Kumar, Catherine Benedict, Lauren C. Heathcote, Catherine Aftandilian, Melissa Bondy, Lidia Schapira
473 [GO] 2021―Jun―02 Disruptions to U.S. medical oncology care during the COVID-19 Pandemic: CancerLinQ Discovery (CLQD) analysis. Abdul-Rahman Jazieh, Mark Riffon, Jennifer C. King, Gabrielle Betty Rocque, Electra D. Paskett, Danielle M. Potter
474 [GO] 2021―Jun―02 Impact of a sustainable breast and cervical cancer screening program in spite of COVID-19 pandemic: The AMPATH experience in Kenya. Stephen Kiptoo, Naftali Wisindi Busakhala, Peter Itsura, Philip Tonui, Terry Vik, Patrick J. Loehrer, Omenge Elkanah Orang'o
475 [GO] 2021―Jun―02 Multifactorial analysis of cancer patients’ willingness for COVID-19 vaccination. Paris A. Kosmidis, Christie Lagogianni, Thanos Kosmidis
476 [GO] 2021―Jun―02 Real-world patient-reported and clinical outcomes of BNT162b2 mRNA COVID-19 vaccine in patients with cancer. Ishwaria Mohan Subbiah, Loretta A. Williams, Angela Peek, Sanjay Shete, Bruno Palma Granwehr, David D'Achiardi, et al. (+14)
477 [GO] 2021―Jun―02 Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis. Michael J Wagner, Matthew Ingham, Corrie Painter, Rashmi Chugh, Jonathan C. Trent, Vivek Subbiah, et al. (+14)
478 [GO] 2021―Jun―02 Randomized trial of remote cancer symptom monitoring during COVID-19: Impact on symptoms, QoL, and unplanned health care utilization. Kathi Mooney, Eli Iacob, Christina M. Wilson, Jennifer Lloyd, Heidi Nielson, John Harris Ward
479 [GO] 2021―Jun―02 Epidemiology and clinical course of SARS-CoV-2 infection in cancer patients in the Veneto Oncology Network during the first and second pandemic waves. Valentina Guarneri, Mario Caccese, Giuseppe Azzarello, Franco Bassan, Vanna Chiarion-Sileni, Rita Chiari, et al. (+13)
480 [GO] 2021―Jun―02 Mortality risk for patients undergoing cancer treatment who acquire SARS-CoV-2: ASCO registry. Kathryn Finch Mileham, Suanna Steeby Bruinooge, Charu Aggarwal, Alicia L. Patrick, Christiana Davis, Daniel Mesenhowski, et al. (+10)
481 [GO] 2021―Jun―02 Supporting the mental well-being of healthcare professionals during a pandemic. Ana Maria Lopez, Lisa Capparella, Miriam Pomerantz, Kristine Naputo, Amy Leader, C. Virginia Virginia O'Hayer
482 [GO] 2021―Jun―02 Reducing racial disparities in time to breast cancer diagnosis: Impact of immediate screening mammogram reads during the COVID pandemic. Janeiro Achibiri, Brian Nicholas Dontchos, Sarah Mercaldo, Anand Narayan, Randy C. Miles, Leslie Lamb, et al. (+2)
483 [GO] 2021―Jun―02 Impact of COVID19 pandemic on treatment outcome of locally-advanced head and neck squamous cell carcinoma (LA-HNSCC): IMPACCT study. Pau Guillen Sentis, Carmen Castillo Manzano, Beatriz Quirós, Francisca Morey Cortes, Sara Tous, Maria Plana, et al. (+14)
484 [GO] 2021―Jun―02 Medicaid patients more likely to die at home without hospice during the pandemic versus before, exacerbating disparities with commercially insured patients. Laura Elizabeth Panattoni, Li Li, Qin Sun, Catherine R. Fedorenko, Hayley Sanchez, Karma L. Kreizenbeck, et al. (+2)
485 [GO] 2021―Mar―02 Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond. Arnav Srivastava, Hiren V. Patel, Sinae Kim, Brian Shinder, Joshua Sterling, Alexandra L. Tabakin, et al. (+8)
486 [GO] 2021―Mar―02 The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer. Vaibhav G. Patel, Xiaobo Zhong, Neil J. Shah, Luis Pina Martina, Jessica Hawley, Emily Lin, et al. (+14)
487 [GO] 2021―Mar―02 Management of localized prostate cancer during the Covid-19 pandemic at a multidisciplinary cancer center in New York City, New York. Andrew Wood, Benjamin Shpeen, Jeffrey Lee, Rose Snyder, Yiqing Xu, Srinath Kotamarti, et al. (+6)
488 [GO] 2021―Mar―02 Assessing the impact of the COVID-19 pandemic on patients with genitourinary malignancies. Hala Borno, Sylvia Zhang, Scarlett Lin Gomez, Celia Kaplan, Christine Miaskowski, Julian Hong, et al. (+3)
489 [GO] 2021―Mar―02 Androgen deprivation therapy and risk of SARS-CoV-2 infection in men with prostate cancer: A University of California (UC) Health System registry study. Daniel Kwon, Rohit Vashisht, Hala Borno, Rahul Raj Aggarwal, Eric Jay Small, Atul Butte, Franklin W. Huang
490 [GO] 2021―Jan―22 COVID-19 infection in gastrointestinal (GI) cancer patients receiving systemic anticancer treatment (SACT) during the outbreak of the pandemic: The Guy's Cancer Centre experience. Eirini Tsotra, Charalampos Gousis, Beth Russell, Charlotte Moss, Kieran Palmer, Ana Montes, et al. (+14)
491 [GO] 2021―Jan―22 Understanding the impact of COVID-19 on the colorectal cancer community: Barriers and opportunities for care. Reese Garcia, Andrea Dwyer, Molly McDonnell
492 [GO] 2021―Jan―22 The impact of changes in service delivery in patients with colorectal cancer during the first peak of the COVID-19 pandemic. Konstantinos Kamposioras, Kok Haw Jonathan Lim, Mark P. Saunders, Kalena Marti, Daniel Anderson, Mark Cutting, et al. (+8)
493 [GO] 2021―Jan―22 Quantifying the impact of the COVID-19 pandemic on gastrointestinal cancer care delivery. Nicholas Perkons, Casey Kim, Chris Boedec, Charles John Schneider, Ursina R. Teitelbaum, Edgar Ben-Josef, et al. (+4)
494 [GO] 2021―Jan―22 Exploring cancer clinical trial participation in the new normal of COVID-19: The patient perspective. Martha Ann Raymond, Margaret-Ann Simonetta
495 [GO] 2020―Dec―08 American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care Nathan A. Pennell, Melissa Dillmon, Laura A. Levit, E. Allyn Moushey, Ajjai S. Alva, Sibel Blau, et al. (+42)
496 [GO] 2020―Oct―08 ED utilization trends for medical oncology patients at Thomas Jefferson University during COVID-19. Zachary L. Quinn, Adam Binder, Valerie Pracilio Csik, Helen Evers-Hunt, Nathan Handley
497 [GO] 2020―Oct―08 Patient-centered communication: Collaborative learning and communication strategies for patient and healthcare providers in the new normal of COVID-19. Martha Ann Raymond, Margaret-Ann Simonetta
498 [GO] 2020―Oct―08 Electronic patient-reported outcomes (ePRO) platform engagement in cancer patients during COVID-19. Susan A Frailley, L. Johnetta Blakely, Leah Owens, Ashley Roush, Toni S. Perry, Veera Hellen, Natalie R. Dickson
499 [GO] 2020―Oct―08 C-CRES: COVID-19 and cancer research engagement study. Louis Fox, Harriet Wylie, Fidelma Cahill, Anna Haire, Joyce Kibaru, Saran Green, et al. (+3)
500 [GO] 2020―Oct―08 Anxiety due to COVID-19 and impact on patients receiving chemotherapy in an inner-city minority population. Muhammad Junaid Tariq, Muhammad Usman Almani, Syed Ali Amir Sherazi, Muhammad Usman, Abdul Wahab Arif, Barbara Yim, Shweta Gupta
501 [GO] 2020―Oct―08 Protecting high-risk oncology patients during the pandemic of COVID-19 by creating an outpatient cancer clinic for febrile neutropenia (California clinic). Manidhar Reddy Lekkala, Mohammad Abedi, Tammy Clarke, Bahar Moftakhar, Arpan Patel
502 [GO] 2020―Oct―08 Disproportionate impact of COVID-19 disease among racial and ethnic minorities in the U.S. cancer population as seen in CancerLinQ Discovery data. Danielle Potter, Mark Riffon, Sirisha Kakamada, Robert S. Miller, George Anthony Komatsoulis
503 [GO] 2020―Oct―08 Racial differences in hospitalizations associated with COVID-19 in patients with cancer. Chintan Pandya, Sishemo Mwesigwa, David W. Dougherty
504 [GO] 2020―Oct―08 Monitoring COVID-19 initiatives and safety concerns at a comprehensive cancer center. Carmen E. Gonzalez, LaTasha Burns, John Bingham, Alana Newman, Tammy Dawson, Lulu Thompson, et al. (+6)
505 [GO] 2020―Oct―08 Effects of COVID-19 on an academic breast oncology center in New York City. Jake Prigoff, Grace Hillyer, Fletcher Bell, Melissa Kate Accordino
506 [GO] 2020―Oct―08 The effects of COVID-19 on new oral oncolytic treatments. Rachel L. Mitchell, Edward Arrowsmith, Jack L. Taylor, Stephen Matthew Schleicher, Natalie R. Dickson, Stacey McCullough
507 [GO] 2020―Oct―08 Psychosocial impacts of COVID-19 on oncology workforces: Metro versus regional Australia. Elizabeth Stephanie Ahern, Harry Michael Gasper, Bryan Chan, Natasha Anne Roberts, Brett Gordon Maxwell Hughes, David Wyld, et al. (+3)
508 [GO] 2020―Oct―08 The effect of COVID-19 on revenue cycle staff. Stacey L Poole, Johnetta Blakely, Cheryl Crouse, Pam Colangelo, Natalie R. Dickson
509 [GO] 2020―Oct―08 A pilot study of risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic. Chelsea K. Osterman, Tammy Triglianos, Gary Winzelberg, Angela Nichols, Julia Rodriguez-O'Donnell, Sharon M Bigelow, et al. (+3)
510 [GO] 2020―Oct―08 Providing uninterrupted oral oncolytic therapies during the COVID-19 pandemic. Edward Arrowsmith, Rachel L. Mitchell, Jack L. Taylor, Stephen Matthew Schleicher, Natalie R. Dickson, Stacey McCullough
511 [GO] 2020―Oct―08 Maintaining treatment volumes during the COVID-19 pandemic. Rachel L. Mitchell, L Johnetta Blakely, Stephen Matthew Schleicher, Stacey L Poole, Natalie R. Dickson, Jeffrey Patton, Davey B. Daniel
512 [GO] 2020―Oct―08 Disparities in the use of telehealth during the COVID-19 pandemic. Cardinale B. Smith, Aarti Sonia Bhardwaj
513 [GO] 2020―Oct―08 Telehealth to expand access of oncology care in Utah during COVID-19 pandemic. David Michael Gill, Terence Duane Rhodes, Jamie Brant, Timothy Joseph Yeatman, Derrick S. Haslem
514 [GO] 2020―Oct―08 Creation of a telehealth task force to improve successful use of telehealth to maintain patient access during the COVID-19 pandemic. Avnish K Bhatia, Lauren Waldman, Melissa Hunt, Amy Leader, Janene Palidora, Megan Sabonjian, et al. (+4)
515 [GO] 2020―Oct―08 Telemedicine usability for cancer care during the COVID-19 pandemic. Christian Miller, Rebecca Davidson Kaltman, Andrea Leon, Andrea Gesteira, Samuel Duffy, Paula Brooke Burgess
516 [GO] 2020―Oct―08 Implementing teleoncology in a safety-net hospital during the COVID-19 pandemic. Andrew James Wiele, Tejal Amar Patel, Kristyn-Mae Russo, Sarah Rizvi, Patricia De Los Rios, Robert Harrison Hester, et al. (+3)
517 [GO] 2020―Oct―08 EHR innovations to optimize cancer care delivery in New York City during the COVID-19 pandemic. Aarti Sonia Bhardwaj, Edward Gu, Joseph Pratko, Michael McLean, Damaris Peralta Hernandez, Cardinale B. Smith
518 [GO] 2020―Oct―08 Analysis of systemic therapy delivery for gastrointestinal cancer patients during the COVID-19 pandemic. Robert Power, Claire O'Donohoe, Cathy Enright, Louise Glennon, Lisa McDowell, David James Gallagher, Maeve Aine Lowery
519 [GO] 2020―Oct―08 Implementation of care near home model (CNH) for cancer patients in response to COVID-19 pandemic. Abdul-Rahman Jazieh, Nashmia Al Mutairi, Abdulrahman Al Hadab, Ashwaq Al Olayan, Ayman Al Hejazi, Abdullah Al Qarni, et al. (+9)
520 [GO] 2020―Oct―08 Utilization of telemedicine to meet the demand throughout the COVID-19 pandemic at a community oncology practice. Larry Edward Bilbrey, Susan A Frailley, Stacey L Poole, Cheryl Crouse, Amanda Trader, L. Johnetta Blakely, et al. (+2)
521 [GO] 2020―Oct―08 The COVID-19 pandemic impact on breast cancer care delivery at an academic center in New York City. Tejus Satish, Rohit Raghunathan, Jake Prigoff, Jason Dennis Wright, Grace Hillyer, Meghna S. Trivedi, et al. (+4)
522 [GO] 2020―Oct―08 Managing the delivery of quality cancer care during the COVID-19 pandemic in a small community cancer clinic. Kashyap B. Patel, Natasha Clinton
523 [GO] 2020―Oct―08 Oncology treatments during COVID-19 pandemic in Israel: ONCOR study. Ido Wolf, Galit Hirsh-Yechezkel, Angela Chetrit, Sivan Ben-Avraham
524 [GO] 2020―Oct―08 Managing outpatient oncology visits during COVID-19 pandemic: Addressing patients' concerns and precautionary measures. Nashmia Al Mutairi, Mohammad Al Harbi, Hussam Shehata, Noridayu Mohammed Rashid, Abdul-Rahman Jazieh
525 [GO] 2020―Oct―08 Emotional impact of COVID-19 preparations on metro and regional cancer workforces in Queensland Australia: "We are all in this together". Natasha Anne Roberts, Bryan Chan, Elizabeth Stephanie Ahern, Harry Michael Gasper, Glen Kennedy, Brett Gordon Maxwell Hughes, et al. (+3)
526 [GO] 2020―Oct―08 Time to COVID-19 RT-PCR clearance among patients with cancer. Wenxin Xu, Andrew Piper-Vallillo, Poorva Bindal, Jonathan W. Wischhusen, Jaymin M. Patel, Daniel Botelho Costa, Mary Linton Bounetheau Peters
527 [GO] 2020―Oct―08 Disparities in COVID-19 severity and risk of death in cancer patients: Experiences from a U.K. cancer center. Beth Russell, Charlotte L Moss, Sophie Papa, Harriet Wylie, Anna Haire, Fidelma Cahill, et al. (+6)
528 [GO] 2020―Oct―08 Perception of patients regarding telemedicine at times of COVID-19: Did they miss the personal touch? Shira Peleg Hasson, Barliz Waissengrin, Marah Hodruj, Eliya Shachar, Sharon Pelles, Ido Wolf
529 [GO] 2020―Oct―08 Active Living After Cancer: Converting a group physical activity intervention for cancer survivors to a virtual format in response to the coronavirus pandemic. Karen Basen-Engquist, Yue Liao
530 [GO] 2020―Oct―08 Using retrospective adverse event data to assess the impact of visitor management during a pandemic emergency plan at a community oncology practice. Larry Edward Bilbrey, Natalie R. Dickson
531 [GO] 2020―Oct―08 The role of telehealth in improving patient care and satisfaction during a pandemic: University of California Cancer Consortium experience. Pelin Cinar, Debra Burgess, Kathryn A. Gold, Maki Yamamoto, Kimberly A. Ternavan, Emi Kamiya
532 [GO] 2020―Oct―06 Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study James C. Glasbey, Aneel Bhangu
533 [GO] 2020―Oct―06 Coronavirus Farewell Catriona M. McNeil
534 [GO] 2020―Sep―28 COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study Gagandeep Brar, Laura C. Pinheiro, Michael Shusterman, Brandon Swed, Evgeniya Reshetnyak, Orysya Soroka, et al. (+7)
535 [GO] 2020―Aug―25 HIV/AIDS pandemic (AP) in Africa: Chronicle of a missed opportunity C. K. Williams
536 [GO] 2020―Aug―14 Chemotherapy and COVID-19 Outcomes in Patients With Cancer Justin Jee, Michael B. Foote, Melissa Lumish, Aaron J. Stonestrom, Beatriz Wills, Varun Narendra, et al. (+14)
537 [GO] 2020―Aug―14 SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic Anna S. Berghoff, Margaretha Gansterer, Arne C. Bathke, Wolfgang Trutschnig, Philipp Hungerländer, Julia M. Berger, et al. (+10)
538 [GO] 2020―Aug―04 COVID-19 and Cancer Care: Ensuring Safety While Transforming Care Delivery Therese M. Mulvey, Joseph O. Jacobson
539 [GO] 2020―Jun―01 Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19). Jeremy Lyle Warner, Sam Rubinstein, Petros Grivas, Toni K. Choueiri, Nicole Maria Kuderer, Dimpy Shah, et al. (+14)
540 [GO] 2020―Jun―01 Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival. Leora Horn, Jennifer G. Whisenant, Valter Torri, Li-Ching Huang, Annalisa Trama, Luis G. Paz-Ares, et al. (+14)
541 [GO] 2020―May―28 A Bitter Elixir: Palliative Chemotherapy During a Pandemic Amie E. Jackson
542 [GO] 2020―Apr―28 Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic Jonathan M. Marron, Steven Joffe, Reshma Jagsi, Rebecca A. Spence, Fay J. Hlubocky
543 [GO] 2020―Apr―08 Challenges Faced by Medical Journals During the COVID-19 Pandemic Stephen A. Cannistra, Bruce G. Haffty, Karla Ballman
 [1] 

543 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.030 sec